{"financebench_id": "financebench_id_03029", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2018 capital expenditure amount (in USD millions) for 3M? Give a response to the question by relying on the details shown in the cash flow statement.", "gold_answer": "$1577.00", "model_answer": "3M’s FY2018 capital expenditures (purchases of property, plant and equipment) were $1,577 million, per “Purchases of property, plant and equipment (PP&E)” in the Consolidated Statement of Cash Flows."}
{"financebench_id": "financebench_id_04672", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Assume that you are a public equities analyst. Answer the following question by primarily using information that is shown in the balance sheet: what is the year end FY2018 net PPNE for 3M? Answer in USD billions.", "gold_answer": "$8.70", "model_answer": "3M's net property, plant and equipment (PP&E) at year-end FY2018 was $8.738 billion (≈ $8.74 billion)."}
{"financebench_id": "financebench_id_00499", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Is 3M a capital-intensive business based on FY2022 data?", "gold_answer": "No, the company is managing its CAPEX and Fixed Assets pretty efficiently, which is evident from below key metrics:\nCAPEX/Revenue Ratio: 5.1%\nFixed assets/Total Assets: 20%\nReturn on Assets= 12.4%", "model_answer": "Short answer: Moderately capital‑intensive.\n\nSupporting FY2022 facts from the 10‑K\n- Net sales: $34,229 million.  \n- Purchases of property, plant & equipment (CapEx): $1,749 million → CapEx / Sales ≈ 1,749 / 34,229 ≈ 5.1%.  \n- Depreciation & amortization: $1,831 million → D&A / Sales ≈ 5.3%.  \n- Property, plant & equipment, net: $9,178 million → PP&E / Sales ≈ 9,178 / 34,229 ≈ 26.8%.  \n- PP&E / Total assets ≈ 9,178 / 46,455 ≈ 19.8%.  \n- 2023 expected CapEx: $1.5–$1.8 billion (management guidance).\n\nInterpretation\n- 3M has material tangible manufacturing assets (PP&E ≈ $9.2B) and spends roughly 5% of sales on capital expenditure annually.  \n- CapEx being close to D&A (2022 CapEx ≈ D&A) indicates spending largely to maintain/replace assets rather than rapid expansion.  \n- By industry standards this is capital‑intensive relative to service/technology companies but modest compared with very heavy‑asset sectors (utilities, oil & gas, basic materials) where CapEx/Sales and PP&E intensity are typically much higher.\n\nConclusion\n3M is a manufacturing company with meaningful capital needs — i.e., moderately capital‑intensive: it must make steady, sizable capital investments (≈$1.5–1.8B/year) to support operations, but it is not among the most capital‑heavy industries."}
{"financebench_id": "financebench_id_01226", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove operating margin change as of FY2022 for 3M? If operating margin is not a useful metric for a company like this, then please state that and explain why.", "gold_answer": "Operating Margin for 3M in FY2022 has decreased by 1.7% primarily due to: \n-Decrease in gross Margin\n-mostly one-off charges including Combat Arms Earplugs litigation, impairment related to exiting PFAS manufacturing, costs related to exiting Russia and divestiture-related restructuring\ncharges", "model_answer": ""}
{"financebench_id": "financebench_id_01865", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "If we exclude the impact of M&A, which segment has dragged down 3M's overall growth in 2022?", "gold_answer": "The consumer segment shrunk by 0.9% organically.", "model_answer": "The Consumer segment. Excluding M&A effects, Consumer organic sales fell 0.9% in 2022 (while Safety & Industrial, Transportation & Electronics and Health Care showed organic growth of 1.0%, 1.2% and 3.2%, respectively)."}
{"financebench_id": "financebench_id_00807", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does 3M have a reasonably healthy liquidity profile based on its quick ratio for Q2 of FY2023? If the quick ratio is not relevant to measure liquidity, please state that and explain why.", "gold_answer": "No. The quick ratio for 3M was 0.96 by Jun'23 close, which needs a bit of an improvement to touch the 1x mark", "model_answer": "Short answer: No — by the classic quick-ratio test 3M’s liquidity in Q2 FY2023 is below the 1.0 benchmark. However, the quick ratio is only one indicator and for a large manufacturer like 3M it should be interpreted with other liquidity metrics (cash, access to credit, operating cash flow, current ratio, and timing of liabilities).\n\nCalculation and numbers (from the 10‑Q, June 30, 2023)\n- Cash & cash equivalents: $4,258 million  \n- Current marketable securities: $56 million  \n- Accounts receivable (net): $4,947 million  \nQuick assets = 4,258 + 56 + 4,947 = $9,261 million\n\n- Current liabilities = $10,936 million\n\nQuick ratio = 9,261 / 10,936 ≈ 0.85\n\nInterpretation\n- A quick ratio of ≈0.85 means 3M’s most liquid resources (cash, marketable securities and receivables) did not fully cover its current liabilities at June 30, 2023. By the traditional rule-of-thumb (≥1.0) that would not be considered “healthy.”\n- That said, the quick ratio is a snapshot and omits other important liquidity sources and context that matter for a large industrial company:\n  - Inventories ($5,280M) are sizable and for many manufacturers are relatively liquid (depending on product mix and demand); including inventory yields the current ratio = current assets / current liabilities = 15,754 / 10,936 ≈ 1.44, which is more comfortable.\n  - 3M had $4.25B committed revolving credit capacity (undrawn at 6/30/23), proved access to commercial paper markets (had $1.8B outstanding at 6/30/23), and substantial operating cash generation (net cash from operations of $2,784M in the first six months of 2023 and free cash flow of $1,932M).\n  - Some large liabilities recorded in 2023 (notably the PFAS-related accrual) are non‑cash or scheduled over many years; the timing of actual cash payments matters a great deal to near‑term liquidity.\n  - Credit ratings, future access to capital markets, and cash‑flow forecasts are also critical for assessing liquidity beyond the quick ratio.\n\nBottom line\n- Purely on the quick ratio (≈0.85) 3M falls short of the ≥1.0 benchmark and would not be judged “healthy” by that single metric.  \n- However, when you consider the broader liquidity picture (cash balances, marketable securities, access to committed credit, commercial paper capacity, and strong operating cash flow), 3M’s overall liquidity profile in Q2 2023 appears manageable — albeit under pressure relative to a stronger quick‑ratio result and with material risk from large contingent and long‑term liabilities that merit close monitoring."}
{"financebench_id": "financebench_id_00941", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which debt securities are registered to trade on a national securities exchange under 3M's name as of Q2 of 2023?", "gold_answer": "Following debt securities registered under 3M's name are listed to trade on the New York Stock Exchange:\n-1.500% Notes due 2026 (Trading Symbol: MMM26)\n-1.750% Notes due 2030 (Trading Symbol: MMM30)\n-1.500% Notes due 2031 (Trading Symbol: MMM31)", "model_answer": "Per 3M’s Form 10‑Q for the quarter ended June 30, 2023, the following debt securities were registered to trade on a national securities exchange (NYSE) under 3M’s name:\n\n- 1.500% Notes due 2026 — trading symbol: MMM26 (New York Stock Exchange)  \n- 1.750% Notes due 2030 — trading symbol: MMM30 (New York Stock Exchange)  \n- 1.500% Notes due 2031 — trading symbol: MMM31 (New York Stock Exchange)"}
{"financebench_id": "financebench_id_01858", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does 3M maintain a stable trend of dividend distribution?", "gold_answer": "Yes, not only they distribute the dividends on a routine basis, 3M has also been increasing the per share dividend for consecutive 65 years", "model_answer": "Yes. 3M shows a stable, consistent dividend trend.\n\nSupport from the filing:\n- Note 7: cash dividends declared and paid were $1.50 per share in each of Q1 and Q2 2023 (vs. $1.49 per share in each of Q1 and Q2 2022), i.e., $3.00 YTD 2023 vs. $2.98 YTD 2022.  \n- MD&A (Item 2): the February 2023 dividend declaration of $1.50 marked the 65th consecutive year of dividend increases; the Board also declared the $1.50 Q2 2023 dividend in May 2023.  \n- Note 10: debt covenants do not restrict the payment of dividends.\n\nTaken together, the company has maintained regular quarterly dividends with a modest increase in early 2023 and a long history of consecutive annual increases."}
{"financebench_id": "financebench_id_02987", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2019 fixed asset turnover ratio for Activision Blizzard? Fixed asset turnover ratio is defined as: FY2019 revenue / (average PP&E between FY2018 and FY2019). Round your answer to two decimal places. Base your judgments on the information provided primarily in the statement of income and the statement of financial position.", "gold_answer": "24.26", "model_answer": "Step 1 — FY2019 revenue (net revenues)\nFrom the Consolidated Statements of Operations: FY2019 net revenues = $6,489 million.\n\nStep 2 — Average PP&E (average of net property & equipment at 12/31/2018 and 12/31/2019)\nFrom the Consolidated Balance Sheets:\n- Property and equipment, net at 12/31/2018 = $282 million\n- Property and equipment, net at 12/31/2019 = $253 million\nAverage PP&E = (282 + 253) / 2 = 267.5 million\n\nStep 3 — Fixed asset turnover ratio = FY2019 revenue / average PP&E\n= 6,489 / 267.5 ≈ 24.26\n\nAnswer: 24.26"}
{"financebench_id": "financebench_id_07966", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2017 - FY2019 3 year average of capex as a % of revenue for Activision Blizzard? Answer in units of percents and round to one decimal place. Calculate (or extract) the answer from the statement of income and the cash flow statement.", "gold_answer": "1.9%", "model_answer": "1.9%\n\nCalculation (from the filing’s consolidated statements of operations and cash flows):\n- FY2017 capex = $155M; revenue = $7,017M → 155 / 7,017 = 2.2099%  \n- FY2018 capex = $131M; revenue = $7,500M → 131 / 7,500 = 1.7467%  \n- FY2019 capex = $116M; revenue = $6,489M → 116 / 6,489 = 1.7879%\n\n3‑year average = (2.2099% + 1.7467% + 1.7879%) / 3 = 1.9143% → 1.9% (rounded to one decimal place)."}
{"financebench_id": "financebench_id_04735", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "You are an investment banker and your only resource(s) to answer the following question is (are): the statement of financial position and the cash flow statement. Here's the question: what is the FY2015 operating cash flow ratio for Adobe? Operating cash flow ratio is defined as: cash from operations / total current liabilities. Round your answer to two decimal places.", "gold_answer": "0.66", "model_answer": "Cash from operations (FY2015) = $1,469,502 (thousands)  \nTotal current liabilities (as of 11/27/2015) = $2,213,556 (thousands)\n\nOperating cash flow ratio = 1,469,502 / 2,213,556 = 0.66 (rounded to two decimal places)"}
{"financebench_id": "financebench_id_07507", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Adobe's year-over-year change in unadjusted operating income from FY2015 to FY2016 (in units of percents and round to one decimal place)? Give a solution to the question by using the income statement.", "gold_answer": "65.4%", "model_answer": "From the Consolidated Statements of Income:\n- Operating income FY2015 = $903,095 thousand = $903.095 million\n- Operating income FY2016 = $1,493,602 thousand = $1,493.602 million\n\nChange = 1,493,602 − 903,095 = 590,507 (thousands)\n\nYear‑over‑year % change = (590,507 / 903,095) × 100 = 65.39% ≈ 65.4%\n\nAnswer: 65.4% increase."}
{"financebench_id": "financebench_id_03856", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2017 operating cash flow ratio for Adobe? Operating cash flow ratio is defined as: cash from operations / total current liabilities. Round your answer to two decimal places. Please utilize information provided primarily within the balance sheet and the cash flow statement.", "gold_answer": "0.83", "model_answer": "Operating cash flow ratio = Cash from operations / Total current liabilities\n\nCash from operations (FY2017) = $2,912,853 (Consolidated Statements of Cash Flows)  \nTotal current liabilities (as of Dec 1, 2017) = $3,527,457 (Consolidated Balance Sheet)\n\nRatio = 2,912,853 / 3,527,457 = 0.83 (rounded to two decimal places)."}
{"financebench_id": "financebench_id_00438", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Adobe have an improving operating margin profile as of FY2022? If operating margin is not a useful metric for a company like this, then state that and explain why.", "gold_answer": "No the operating margins of Adobe have recently declined from 36.8% in FY 2021 to 34.6% in FY2022. A drop by 2.2% in a year.", "model_answer": ""}
{"financebench_id": "financebench_id_00591", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Adobe have an improving Free cashflow conversion as of FY2022?", "gold_answer": "Yes, the FCF conversion (using net income as the denominator) for Adobe has improved by ~13% from 143% in 2021 to 156% in 2022", "model_answer": "Yes — Adobe’s free cash flow conversion improved in FY2022.\n\nCalculation (using the company’s statements):\n\n- Net cash provided by operating activities (CFO): $7,838 million (FY2022); $7,230 million (FY2021); $5,727 million (FY2020). (Consolidated Statements of Cash Flows)\n- Purchases of property and equipment (capex): $442 million (FY2022); $348 million (FY2021); $419 million (FY2020). (Consolidated Statements of Cash Flows)\n- Net income: $4,756 million (FY2022); $4,822 million (FY2021); $5,260 million (FY2020). (Consolidated Statements of Income)\n\nFree cash flow (CFO − capex):\n- 2022: 7,838 − 442 = $7,396 million\n- 2021: 7,230 − 348 = $6,882 million\n- 2020: 5,727 − 419 = $5,308 million\n\nFree cash flow conversion = Free cash flow / Net income:\n- 2022: 7,396 / 4,756 ≈ 155.5%\n- 2021: 6,882 / 4,822 ≈ 142.7%\n- 2020: 5,308 / 5,260 ≈ 100.9%\n\nConclusion: Free cash flow conversion rose from ~101% (2020) to ~143% (2021) to ~156% (2022), so yes — Adobe’s free cash flow conversion improved as of FY2022."}
{"financebench_id": "financebench_id_10420", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Based on the information provided primarily in the statement of financial position and the statement of income, what is AES's FY2022 return on assets (ROA)? ROA is defined as: FY2022 net income / (average total assets between FY2021 and FY2022). Round your answer to two decimal places.", "gold_answer": "-0.02", "model_answer": "ROA = FY2022 net income / average total assets\n\nFY2022 net income = −$546 million\nAverage total assets = (Total assets 2022 $38,363m + Total assets 2021 $32,963m) / 2 = $35,663m\n\nROA = −546 / 35,663 = −0.01531 = −1.53% (rounded to two decimal places)"}
{"financebench_id": "financebench_id_01319", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the quantity of restructuring costs directly outlined in AES Corporation's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.", "gold_answer": "0", "model_answer": "0\n\nReason: The filing states (Non‑GAAP Measures section) that the company removed the adjustment for costs \"directly associated with a major restructuring program\" and explicitly notes \"There were no such costs in 2020, 2021 or 2022.\""}
{"financebench_id": "financebench_id_00540", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Roughly how many times has AES Corporation sold its inventory in FY2022? Calculate inventory turnover ratio for the FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.", "gold_answer": "AES has converted inventory 9.5 times in FY 2022.", "model_answer": "Short answer\nI can’t calculate a numeric inventory-turnover ratio from the pages of the 10‑K you supplied because those pages don’t include the Company’s year‑end inventory balances. I can, however:\n\n- show the formula and compute cost of goods sold (COGS) for FY2022 from the amounts in the filing you supplied (COGS = Revenue − Cost of sales / Operating margin), and\n- explain why an inventory‑turnover ratio is of limited usefulness for AES and what it would mean if you want a numeric result.\n\nWhat I can compute from the filing excerpt you gave\nFrom the Consolidated results shown in the filing excerpt:\n- Revenue (2022) = $12,617 million\n- Operating margin (2022) = $2,548 million\n\nSo:\nCOGS (2022) = Revenue − Operating margin = 12,617 − 2,548 = $10,069 million\n\nInventory‑turnover ratio = COGS / Average inventory\n\nTo get a numeric ratio for FY2022 I need the company’s inventory balance at 12/31/2022 and at 12/31/2021 (to compute average inventory). Those figures are normally in the Consolidated Balance Sheet or Note 2 — Inventory (both are listed in the 10‑K table of contents), but those pages were not included in the excerpt you provided.\n\nIf you want a number\n- If you supply AES’s inventory balances for 12/31/2022 and 12/31/2021 (or the year‑end 2022 inventory and I use it as an approximation for average inventory), I will compute the turnover immediately.\n- Or I can extract the inventory balances from the full Form 10‑K (Note 2 and the balance sheet) and compute the FY2022 turnover for you—tell me if you want me to do that.\n\nWhy “inventory turnover” may be of limited meaning for AES\nAES is an electric power company (generation, utilities, renewables and storage). For companies like AES:\n- Reported “inventory” usually consists primarily of fuel stocks (coal, spare fuel), spare parts and materials—not goods held for resale in the same way as a retailer or manufacturer.\n- Much of AES’s cost base is fuel and purchased power that is passed through to counterparties under contracts, or is hedged financially, and a large portion of the Company’s sales are under long‑term PPAs or regulated tariffs. That reduces the operational relevance of the simple COGS / average inventory metric that is designed for merchandising/manufacturing firms.\n- Energy businesses are typically capital‑intensive and the useful liquidity/efficiency metrics tend to be things like: days payable outstanding, working capital (ex‑contract pass‑throughs), generation availability, contract coverage, and cash flows from operations—not inventory turnover.\nSo even if we compute a numerical inventory‑turnover ratio, its interpretation should be cautious: a high turnover could simply reflect the small book inventory of fuel/spares versus very large COGS; a low turnover could reflect seasonal fuel stocking or long lead‑time spares rather than poor inventory control.\n\nNext step\nTell me which you prefer:\n- Paste AES’s inventory balances for 12/31/2022 and 12/31/2021 and I’ll compute the turnover now; or\n- Give me permission to fetch the Inventory and Balance Sheet lines from the full 2022 Form 10‑K and I’ll compute and report the exact FY2022 inventory turnover with brief interpretation."}
{"financebench_id": "financebench_id_06655", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Amazon's FY2017 days payable outstanding (DPO)? DPO is defined as: 365 * (average accounts payable between FY2016 and FY2017) / (FY2017 COGS + change in inventory between FY2016 and FY2017). Round your answer to two decimal places. Address the question by using the line items and information shown within the balance sheet and the P&L statement.", "gold_answer": "93.86", "model_answer": "Answer: 93.86 days\n\nWorkings (all line items from the filing):\n\n- Accounts payable, 12/31/2016 = $25,309 million (Consolidated Balance Sheet)  \n- Accounts payable, 12/31/2017 = $34,616 million (Consolidated Balance Sheet)  \n- Average accounts payable = (25,309 + 34,616) / 2 = 29,962.5 million\n\n- FY2017 COGS (Cost of sales) = $111,934 million (Consolidated Statement of Operations)  \n- Inventory, 12/31/2016 = $11,461 million (Consolidated Balance Sheet)  \n- Inventory, 12/31/2017 = $16,047 million (Consolidated Balance Sheet)  \n- Change in inventory = 16,047 − 11,461 = 4,586 million\n\nDenominator = FY2017 COGS + change in inventory = 111,934 + 4,586 = 116,520 million\n\nDPO = 365 * (average accounts payable) / (COGS + change in inventory)\n    = 365 * 29,962.5 / 116,520\n    = 93.86 days (rounded to two decimals)"}
{"financebench_id": "financebench_id_08135", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Amazon's year-over-year change in revenue from FY2016 to FY2017 (in units of percents and round to one decimal place)? Calculate what was asked by utilizing the line items clearly shown in the statement of income.", "gold_answer": "30.8%", "model_answer": "Using the Consolidated Statements of Operations \"Total net sales\" line:\n\n2016 net sales = $135,987 million\n2017 net sales = $177,866 million\n\nChange = (177,866 − 135,987) / 135,987 = 41,879 / 135,987 ≈ 0.30796 = 30.8%\n\nAnswer: 30.8% year‑over‑year increase (FY2016 → FY2017)."}
{"financebench_id": "financebench_id_08286", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "By drawing conclusions from the information stated only in the income statement, what is Amazon's FY2019 net income attributable to shareholders (in USD millions)?", "gold_answer": "$11588.00", "model_answer": "Amazon's FY2019 net income (from the Consolidated Statement of Operations) is $11,588 million."}
{"financebench_id": "financebench_id_03882", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Amcor's year end FY2020 net AR (in USD millions)? Address the question by adopting the perspective of a financial analyst who can only use the details shown within the balance sheet.", "gold_answer": "$1616.00", "model_answer": "Answering strictly from the consolidated balance sheet presented in the filing:\n\nAmcor's FY2020 year‑end net accounts receivable (reported as \"Trade receivables, net\") = $1,615.9 million (as of June 30, 2020)."}
{"financebench_id": "financebench_id_01935", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What was the key agenda of the AMCOR's 8k filing dated 1st July 2022?", "gold_answer": "Amcor Finance (USA), Inc. and Amcor Flexibles North America, Inc., entered into supplemental indentures relating to Guaranteed Senior Notes due 2026 and 2028. This involved the substitution of the Substitute Issuer (Amcor Flexibles North America) for the Former Issuer (Amcor Finance) and the assumption of covenants under the indentures. (In essence a novation agreement)", "model_answer": "The Form 8-K reported that, effective June 30, 2022, Amcor subsidiaries entered into supplemental indentures to substitute Amcor Flexibles North America, Inc. for Amcor Finance (USA), Inc. as the issuer under the applicable indentures. In short, the filing's key agenda was the issuer substitution and the Substitute Issuer’s assumption of the covenants and obligations with respect to the outstanding 3.625% Guaranteed Senior Notes due 2026 and 4.500% Guaranteed Senior Notes due 2028 (and related procedural matters such as appointment of an agent for service of process)."}
{"financebench_id": "financebench_id_01936", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the nature & purpose of AMCOR's restructuring liability as oF Q2 of FY2023 close?", "gold_answer": "87% of the total restructuring liability is related Employee liabilities.", "model_answer": "Summary — nature and purpose of the restructuring liability (as of Amcor Q2 FY2023 close, December 31, 2022)\n\n- What it is (nature)\n  - A liability accrual of $93 million recorded for restructuring costs (balance at Dec 31, 2022).  \n  - Composition (per Note 6): Employee costs $81m, fixed‑asset related costs $2m, other costs $10m.  \n  - These accruals relate to outcomes of restructuring initiatives (primarily employee termination/related obligations, asset/plant related costs and other contract/closure costs).\n\n- Why it exists (purpose)\n  - To cover expected cash outflows and obligations arising from the Company’s restructuring programs (including actions related to the Russia–Ukraine conflict and the tail end of the 2019 Bemis integration plan).  \n  - The accruals are intended to fund severance and other employee‑related payments, costs to relocate/close or dispose of fixed assets, and other restructuring settlements.\n\n- Presentation and timing\n  - The accruals are recorded in “other current liabilities” and “other non‑current liabilities” on the balance sheet.  \n  - Amcor expects the majority of the employee, fixed asset and other costs included in the $93m liability to be paid within the next twelve months.  \n\n(Disclosure source: Amcor plc Form 10‑Q, Notes 3 and 6 — “Restructuring and other related activities” and “Restructuring”.)"}
{"financebench_id": "financebench_id_01928", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What Was AMCOR's Adjusted Non GAAP EBITDA for FY 2023", "gold_answer": "AMCOR's Adj. EBITDA was $2,018mn in FY 2023", "model_answer": "Amcor's adjusted (non-GAAP) EBITDA for FY 2023 was $2,018 million (US$)."}
{"financebench_id": "financebench_id_01930", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How much was the Real change in Sales for AMCOR in FY 2023 vs FY 2022, if we exclude the impact of FX movement, passthrough costs and one-off items?", "gold_answer": "The Real Growth was flat in FY 2023 vs FY 2022.", "model_answer": "Amcor's net sales were effectively flat year‑over‑year after excluding FX, raw‑material pass‑through and items affecting comparability — i.e. a 0% change (in line with FY2022).  \n\n(Underlying detail: price/mix ≈ +3% offset by volumes ≈ -3% on a comparable constant‑currency, comparable basis.)"}
{"financebench_id": "financebench_id_01079", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are major acquisitions that AMCOR has done in FY2023, FY2022 and FY2021?", "gold_answer": "Amcor completed these acquisitions during FY2023:\n-100% equity interest of a flexibles manufacturing company in the Czech Republic\n- 100% equity interest in a medical device packaging manufacturing site in\nShanghai, China.\n-acquisition of a New Zealand-based leading manufacturer of state-of-the-art, automated protein\npackaging machines.", "model_answer": "Short answer (from Amcor plc Form 10‑K – Note 5, “Acquisitions and Divestitures”):\n\n- Fiscal 2023 (year ended June 30, 2023) — material acquisitions:\n  - August 1, 2022 — acquired a Czech Republic flexible‑packaging company (a world‑class manufacturing plant). Purchase consideration: $59 million (including $5 million deferred). Recognized identifiable net assets ~$36m and goodwill ~$23m. (Flexibles segment.)\n  - March 17, 2023 — acquired a medical‑device packaging manufacturing site in Shanghai, China. Purchase consideration: $60 million (subject to customary post‑closing adjustments) including contingent consideration of $20 million payable over three years subject to performance targets. Preliminary allocation: identifiable net assets ~$21m and goodwill ~$39m. (Flexibles segment.)\n  - May 31, 2023 — acquired a New Zealand manufacturer of automated protein‑packaging machines. Purchase consideration: $45 million (subject to post‑closing adjustments) including contingent consideration of $13 million payable over two years subject to performance targets. Preliminary allocation: identifiable net assets ~$9m and goodwill ~$36m. (Flexibles segment.)\n\n- Fiscal 2022 (year ended June 30, 2022):\n  - The Form 10‑K does not report any material business acquisitions in FY2022. Note 5 describes disposals of non‑core assets (and Russia/Ukraine‑related impairment and later sale activity), but no material acquisitions in that fiscal year.\n\n- Fiscal 2021 (year ended June 30, 2021):\n  - The Form 10‑K does not report any material business acquisitions in FY2021. Note 5 describes disposals of non‑core businesses (and the prior AMVIG sale), but no material acquisitions in that fiscal year.\n\nSource: Amcor plc Annual Report on Form 10‑K for the fiscal year ended June 30, 2023 — Note 5 “Acquisitions and Divestitures” (Part II, Item 8)."}
{"financebench_id": "financebench_id_01148", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What industry does AMCOR primarily operate in?", "gold_answer": "Amcor is a global leader in packaging production for various use cases.", "model_answer": "Amcor primarily operates in the packaging industry — designing and manufacturing flexible and rigid packaging (for food, beverage, pharmaceutical, medical, home and personal‑care, and related products)."}
{"financebench_id": "financebench_id_00799", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has AMCOR's quick ratio improved or declined between FY2023 and FY2022? If the quick ratio is not something that a financial analyst would ask about a company like this, then state that and explain why.", "gold_answer": "The quick ratio has slightly improved from 0.67 times to 0.69 times between FY 2023 and FY 2022.(3.4% jump)", "model_answer": "Short answer: Improved slightly.\n\nCalculation (using the standard quick‑ratio definition = (cash + receivables + marketable securities) / current liabilities — Amcor has no material marketable securities on the balance sheet):\n\n- As of June 30, 2023 (FY2023)\n  - Cash and cash equivalents = $689m\n  - Trade receivables, net = $1,875m\n  - Current liabilities = $4,476m\n  - Quick ratio = (689 + 1,875) / 4,476 = 2,564 / 4,476 ≈ 0.57\n\n- As of June 30, 2022 (FY2022)\n  - Cash and cash equivalents = $775m\n  - Trade receivables, net = $1,935m\n  - Current liabilities = $5,103m\n  - Quick ratio = (775 + 1,935) / 5,103 = 2,710 / 5,103 ≈ 0.53\n\nSo the quick ratio rose from about 0.53 at June 30, 2022 to about 0.57 at June 30, 2023 — a modest improvement.\n\nIs the quick ratio a key metric for an analyst covering Amcor?\n- It is a useful high‑level liquidity snapshot, but for a large industrial/manufacturing packaging company like Amcor analysts typically focus more on:\n  - operating cash flow and free cash flow,\n  - working‑capital metrics such as days inventory outstanding, days sales outstanding and cash conversion cycle,\n  - net debt, leverage (net debt / EBITDA) and covenant headroom,\n  - availability under committed credit facilities / commercial paper backstops (Amcor reported $1.3bn undrawn as of June 30, 2023),\n  - and interest‑coverage metrics.\n- Reason: Amcor carries substantial inventories as part of normal operations, and liquidity management for such companies relies heavily on committed funding lines, commercial paper, and cash‑flow generation rather than only on the “acid test.” The quick ratio can understate usable liquidity for such firms (and can be volatile), so it’s typically one of several measures analysts look at rather than the primary one."}
{"financebench_id": "financebench_id_00684", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does AMCOR have an improving gross margin profile as of FY2023? If gross margin is not a useful metric for a company like this, then state that and explain why.", "gold_answer": "No. For AMCOR there has been a slight decline in gross margins by 0.8%.", "model_answer": "Short answer: No. Amcor’s consolidated gross margin declined in FY2023 (18.5%) versus FY2022 (19.4%) and FY2021 (≈21.2%), so it did not show an improving gross‑margin profile in FY2023.\n\nSupporting detail from the 10‑K\n- Consolidated gross profit (MD&A / Consolidated Gross Profit table):\n  - FY2023: $2,725m; gross profit margin 18.5%\n  - FY2022: $2,820m; gross profit margin 19.4%\n  - FY2021: $2,732m; gross profit margin ≈21.2% (calculated from reported sales)\n- Management also discloses that gross profit as a percentage of sales “decreased to 18.5% in fiscal year 2023, mainly from the impact on the calculation from the pass‑through of higher raw material costs during the current fiscal period and the impact of disposed operations.”\n\nWhy gross margin is a noisy / limited metric for Amcor\n- Raw‑material pass‑throughs: Amcor frequently passes higher resin/commodity costs directly through to customers; the company explicitly discloses large “pass‑through” amounts (e.g., ~$776m consolidated; $516m in Flexibles). Pass‑through increases both reported sales and cost of sales and can materially swing the gross‑margin ratio even though the underlying operating economics (pricing execution, plant efficiency, product mix) may be different.\n- Currency, disposals and one‑off items: Translation effects, business disposals (e.g., Russia), and one‑time impairments or gains distort year‑over‑year gross margins.\n- Business mix and contract mechanics: Amcor sells different product types (flexible vs rigid, specialty cartons, closures) and has customer contracts with pricing mechanisms (indexation, rebates), so gross margin alone can hide underlying operating performance.\n\nWhat management uses instead\n- Amcor reports and discusses non‑GAAP operating measures (Adjusted EBIT and Adjusted EBIT margin) which exclude certain items and are the company’s preferred metric for operating performance. For example, Flexibles Adjusted EBIT margin fell from 13.6% in FY2022 to 12.8% in FY2023 — consistent with the gross‑margin deterioration but presented in a way that strips out some non‑operating items and acquisition accounting.\n\nBottom line / practical guidance\n- Gross margin at Amcor worsened in FY2023 and is therefore not “improving.”\n- Furthermore, because of large raw‑material pass‑throughs, currency and disposals, gross margin is a noisy metric for assessing underlying operating performance in this business. Use management’s Adjusted EBIT (and segment adjusted‑EBIT margins) or gross profit adjusted to exclude pass‑through amounts when you want a clearer view of operating margin trends."}
{"financebench_id": "financebench_id_03069", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Answer the following question as if you are an equity research analyst and have lost internet connection so you do not have access to financial metric providers. According to the details clearly outlined within the P&L statement and the statement of cash flows, what is the FY2015 depreciation and amortization (D&A from cash flow statement) % margin for AMD?", "gold_answer": "4.2%", "model_answer": "Short answer (analyst view, offline calculation):\n\n- FY2015 depreciation & amortization per cash‑flow statement = $167 million.  \n- FY2015 net revenue (P&L) = $3,991 million.  \n- D&A % margin = 167 / 3,991 = 0.0419 ≈ 4.2%.\n\nSo AMD’s FY2015 D&A margin is about 4.2% (using the cash‑flow D&A and consolidated revenue from the 2015 10‑K)."}
{"financebench_id": "financebench_id_00917", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove operating margin change as of the FY22 for AMD? If operating margin is not a useful metric for a company like this, then please state that and explain why.", "gold_answer": "The decrease in AMD's operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition", "model_answer": ""}
{"financebench_id": "financebench_id_00757", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Did AMD report customer concentration in FY22?", "gold_answer": "Yes, one customer accounted for 16% of consolidated net revenue", "model_answer": "Yes.\n\nAMD disclosed customer concentration in its 2022 Form 10-K. Specifically:\n- “One customer accounted for 16% of our consolidated net revenue for the year ended December 31, 2022. Sales to this customer consisted of sales of products from our Gaming segment.” (see “Customers”)\n- The filing also notes concentration in receivables: “One customer accounted for approximately 18% of the total consolidated accounts receivable balance as of December 31, 2022.” (see “Concentrations of Credit Risk”)\n\nThe company further stated that loss of that customer would have a material adverse effect on its business."}
{"financebench_id": "financebench_id_00995", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are the major products and services that AMD sells as of FY22?", "gold_answer": "AMD sells server microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and Adaptive System-on-Chip (SoC) products for data centers; CPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers; discrete GPUs, and semi-custom SoC products and development services; and embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.", "model_answer": "Short answer — as of FY22 AMD’s major products and services are high‑performance and adaptive computing solutions organized around four end‑market segments:\n\n- Data Center\n  - Server CPUs: AMD EPYC family (e.g., EPYC 9004/7003/7002 series)\n  - Data‑center GPUs/accelerators: AMD Instinct family (MI200 series) and Radeon PRO V / visual‑cloud GPUs\n  - DPUs (Pensando) and related software for offloading network/storage/security services\n  - FPGAs, Adaptive SoCs and ACAPs (Xilinx product families) and Alveo accelerator cards\n  - Related software/platforms for data center acceleration (e.g., ROCm)\n\n- Client (desktop & mobile PCs)\n  - Desktop and notebook CPUs and APUs: AMD Ryzen (including Ryzen 7000/6000/5000), AMD Athlon, Ryzen Threadripper / Threadripper PRO\n  - Commercial/enterprise SKUs: Ryzen PRO, Athlon PRO, Ryzen PRO mobile families\n  - Chipsets and platform technologies (AM5/AM4 chipsets, Infinity Fabric)\n\n- Gaming\n  - Discrete GPUs (consumer): AMD Radeon RX series (RDNA2/RDNA3)\n  - Professional GPUs: AMD Radeon PRO (workstation)\n  - Semi‑custom SoCs and co‑development services (console SoCs used in PlayStation 5, Xbox Series S/X; Valve Steam Deck)\n  - Graphics software and developer toolkits (Radeon Software, FidelityFX, FidelityFX Super Resolution)\n\n- Embedded\n  - Embedded CPUs/APUs: Embedded EPYC, Embedded Ryzen (V‑Series, R‑Series, G‑Series), Geode/low‑power variants\n  - FPGA and Adaptive SoC product lines (Virtex, Kintex, Spartan families; Zynq; Versal; RFSoC)\n  - Development boards, kits, design tools and IP (Vivado, Vitis, Vitis AI, Kria SOMs)\n\n- Cross‑cutting software, tools and services\n  - SDKs, drivers, compilers and developer toolchains (ROCm, Vitis, Vivado, Radeon Software)\n  - System and custom design services (semi‑custom SoC development, non‑recurring engineering fees)\n  - IP licensing and occasional IP sales/licenses\n  - FPGA/accelerator cloud offerings and FPGA‑as‑a‑Service partnerships\n\nIn short, AMD sells CPUs, GPUs and accelerated compute products (including DPUs, FPGAs and Adaptive SoCs), semi‑custom SoCs and associated software platforms, plus development services, boards/kits and IP/licenses (as described throughout the FY22 10‑K)."}
{"financebench_id": "financebench_id_00563", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "From FY21 to FY22, excluding Embedded, in which AMD reporting segment did sales proportionally increase the most?", "gold_answer": "Data Center", "model_answer": "Data Center — revenues rose from $3,694M in FY21 to $6,043M in FY22, an increase of about 64% (the largest proportional gain excluding Embedded)."}
{"financebench_id": "financebench_id_00222", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does AMD have a reasonably healthy liquidity profile based on its quick ratio for FY22? If the quick ratio is not relevant to measure liquidity, please state that and explain why.", "gold_answer": "Yes. The quick ratio is 1.57, calculated as (cash and cash equivalents+Short term investments+Accounts receivable, net+receivables from related parties)/ (current liabilities).", "model_answer": "Short answer\nYes — AMD’s quick ratio for FY2022 indicates a reasonably healthy near‑term liquidity position. The quick ratio (cash + short‑term investments + receivables, excluding inventories) is about 1.6x for FY22, i.e., readily liquid current assets exceed current liabilities.\n\nHow I calculated it (from the 10‑K, consolidated balance sheet at 12/31/2022)\n- Cash and cash equivalents: $4,835 million  \n- Short‑term investments: $1,020 million  \n- Accounts receivable, net: $4,126 million  \n- Current liabilities: $6,369 million\n\nQuick ratio = (cash + short‑term investments + accounts receivable) / current liabilities\n= (4,835 + 1,020 + 4,126) / 6,369 ≈ 9,981 / 6,369 ≈ 1.57\n\n(If you use the alternative quick‑asset definition current assets − inventories, you get (15,019 − 3,771) / 6,369 ≈ 1.77.)\n\nInterpretation and context\n- A quick ratio above 1 generally signals that a company can meet its short‑term obligations with its most liquid assets. AMD’s ~1.6x quick ratio therefore points to a reasonably healthy near‑term liquidity profile.  \n- Other supportive datapoints from the filing: cash + short‑term investments ≈ $5.9 billion; operating cash flow in 2022 ≈ $3.6 billion; total debt principal outstanding ≈ $2.5 billion; an unused $3.0 billion revolving credit facility and a $3.0 billion commercial paper program (no commercial paper outstanding at year end). Those items reinforce the view that AMD had adequate liquidity going into 2023.\n\nCaveats / limits of the quick ratio in this case\n- The quick ratio is a snapshot and does not reflect the timing of cash inflows and outflows (e.g., whether receivables will collect quickly or purchase commitments will need near‑term cash). AMD discloses large unconditional purchase commitments (~$8.6 billion total, with ~$6.5 billion in 2023), which can materially affect near‑term cash needs despite a healthy quick ratio.  \n- The semiconductor business has working‑capital idiosyncrasies (prepayments to suppliers, inventory staging for new process nodes, long vendor lead times). These items can make the quick ratio less informative than when applied to other industries, so it should be used together with cash flow, available credit, and the schedule of near‑term commitments.  \n- Quick ratio does not address contingent liabilities or acquisition‑related amortization and other non‑cash items that affect reported earnings and might influence covenant testing or financing plans.\n\nBottom line\nAMD’s FY22 quick ratio (~1.6) supports the conclusion that the company had a reasonably healthy short‑term liquidity position at year end. However, that metric should be viewed alongside cash flow, debt, available credit, and the company’s sizable near‑term purchase commitments to get a complete picture of liquidity risk."}
{"financebench_id": "financebench_id_01198", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove revenue change as of the FY22 for AMD?", "gold_answer": "In 2022, AMD reported Higher sales of their EPYC server processors, higher semi-custom product sales, and the inclusion of Xilinx embedded product sales", "model_answer": "AMD’s FY2022 revenue change (net revenue up 44% to $23.6B from $16.4B in 2021) was driven by:\n\n- Data Center: +64% to $6.0B — primarily higher sales of EPYC server processors (major contributor to the overall increase).  \n- Gaming: +21% to $6.8B — principally higher semi‑custom SoC sales (game console demand).  \n- Embedded: large increase to $4.6B — mainly from the inclusion of Xilinx embedded product sales following AMD’s February 2022 acquisition of Xilinx.  \n\nPartially offset by:\n- Client: −10% to $6.2B — lower processor shipments due to a weak PC market and significant inventory correction across the PC supply chain in the second half of 2022.\n\n(Also: overall gross margin declined modestly due in part to amortization of acquisition‑related intangibles from the Xilinx acquisition.)"}
{"financebench_id": "financebench_id_01279", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for AMD in FY22?", "gold_answer": "In 2022, AMD brought in the most cashflow from Operations", "model_answer": "Operating activities — they provided the most cash in FY2022: net cash provided by operating activities was $3,565 million. Investing activities provided $1,999 million, and financing activities were a net use of cash of $3,264 million. (See “Management’s Discussion…/Liquidity and Capital Resources” and the Consolidated Statements of Cash Flows.)"}
{"financebench_id": "financebench_id_00720", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove gross margin change as of the FY2022 for American Express? If gross margin is not a useful metric for a company like this, then please state that and explain why.", "gold_answer": "Performance is not measured through gross margin", "model_answer": ""}
{"financebench_id": "financebench_id_01351", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How much has the effective tax rate of American Express changed between FY2021 and FY2022?", "gold_answer": "The effective tax rate for American Express has changed/dropped from 24.6% in FY 2021 to 21.6% in FY 2022.", "model_answer": "The effective tax rate decreased by 3.0 percentage points — from 24.6% in FY2021 to 21.6% in FY2022 (a ~12.2% relative decrease)."}
{"financebench_id": "financebench_id_01964", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What was the largest liability in American Express's Balance Sheet in 2022?", "gold_answer": "Customer deposits", "model_answer": "The largest liability was customer deposits — $110,239 million (approximately $110.2 billion) as of December 31, 2022 (see Consolidated Balance Sheets)."}
{"financebench_id": "financebench_id_00476", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which debt securities are registered to trade on a national securities exchange under American Express' name as of 2022?", "gold_answer": "There are none", "model_answer": "None. The Form 10‑K lists only Common Shares (AXP) registered on the New York Stock Exchange; no debt securities are shown as registered to trade on a national securities exchange as of 2022."}
{"financebench_id": "financebench_id_01028", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are the geographies that American Express primarily operates in as of 2022?", "gold_answer": "United States, EMEA, APAC, and LACC", "model_answer": "American Express operates worldwide, with its principal footprint in the United States and internationally across roughly 103 countries and territories.  The jurisdictions that represented a significant portion of its billed business outside the U.S. in 2022 were the United Kingdom (UK), the European Union (EU), Australia, Japan, Canada and Mexico."}
{"financebench_id": "financebench_id_00723", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does AMEX have an improving operating margin profile as of 2022? If operating margin is not a useful metric for a company like this, then state that and explain why.", "gold_answer": "Performance is not measured through operating margin", "model_answer": ""}
{"financebench_id": "financebench_id_01981", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Was American Express able to retain card members during 2022?", "gold_answer": "Yes", "model_answer": "Yes.\n\nEvidence in the 2022 Form 10‑K:\n- Management explicitly states that “new card acquisitions reached record levels in 2022 and Card Member retention remained high.” (MD&A — Executive Overview)\n- Related metrics show growth in the customer base and engagement in 2022 vs. 2021:\n  - Proprietary cards‑in‑force increased to 76.7 million (Dec 31, 2022) from 71.4 million (Dec 31, 2021).\n  - Net card fees rose (reflecting more cards and continued membership fees) and average fee per card increased (from $74 in 2021 to $82 in 2022).\n  - Billed business and Card Member spending also increased, indicating continued member engagement.\n\nTogether, the management commentary plus these metrics support that American Express was able to retain Card Members during 2022."}
{"financebench_id": "financebench_id_05718", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How much (in USD billions) did American Water Works pay out in cash dividends for FY2020? Compute or extract the answer by primarily using the details outlined in the statement of cash flows.", "gold_answer": "$0.40", "model_answer": "American Water paid $389 million in cash dividends in FY2020, which is $0.389 billion (per the \"Dividends paid\" line in the Consolidated Statements of Cash Flows for the year ended December 31, 2020)."}
{"financebench_id": "financebench_id_04254", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Basing your judgments off of the cash flow statement and the income statement, what is American Water Works's FY2021 unadjusted operating income + depreciation and amortization from the cash flow statement (unadjusted EBITDA) in USD millions?", "gold_answer": "$1832.00", "model_answer": "Unadjusted EBITDA = Operating income (FY2021) + Depreciation & amortization (FY2021)\n\n= $1,196m (Operating income) + $636m (Depreciation & amortization)\n\n= $1,832 million."}
{"financebench_id": "financebench_id_00070", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does American Water Works have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.", "gold_answer": "No, American Water Works had negative working capital of -$1561M in FY 2022.", "model_answer": "Short answer: No. As of December 31, 2022 American Water had negative working capital.\n\nDetails / source numbers (FY2022, Form 10‑K):\n- Current assets (12/31/2022): $1,250 million  \n- Current liabilities (12/31/2022): $2,811 million  \n- Working capital = current assets − current liabilities = $1,250m − $2,811m = −$1,561 million (deficit)  \n(Values from the Consolidated Balance Sheets in the filing.)\n\nWhy that negative working capital is not necessarily a sign of liquidity distress and why “working capital” is a limited metric for this company\n- Regulated utilities (and utility holding structures) are capital intensive and typically finance long‑lived rate‑regulated assets with a mix of short‑term and long‑term financing. It is therefore common to see current liabilities (commercial paper, current portion of long‑term debt, accrued items) exceed current assets.\n- American Water relies on other liquidity sources and regulatory recovery rather than a large current‑asset buffer: at 12/31/2022 it had cash + available revolving credit capacity = $85m + $1,495m = $1,580m of readily available liquidity (filing, “Liquidity and Capital Resources”), plus ongoing operating cash flow (2022 net cash provided by operations = $1,108m). The company also has access to commercial paper and a $2.75bn revolving credit facility to manage short‑term needs.\n- Many balances on a utility balance sheet are rate‑making / regulatory items (regulatory assets and liabilities, EADIT amortization, contributions in aid of construction, deferrals) that make a simple current‑assets minus current‑liabilities calculation less informative about the utility’s ability to operate and recover costs through rates.\n- Rating/covenant context matters: the company remained in compliance with debt covenants (consolidated debt / capitalization 0.62 at 12/31/2022 < 0.70 covenant) and completed long‑term and short‑term financings during the year.\n\nConclusion and practical guidance\n- Fact: American Water’s working capital at FY2022 is negative about $1.56 billion.  \n- Interpretation: That negative working capital is common for a regulated, capital‑intensive utility holding company and should not be viewed in isolation as an indicator of financial weakness. For regulated utilities like American Water, more useful liquidity/financial measures are: available cash + undrawn credit capacity, commercial paper capacity and usage, cash flow from operations, access to long‑term debt markets, regulatory recovery mechanisms, and covenant/rating status."}
{"financebench_id": "financebench_id_02608", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "In agreement with the information outlined in the income statement, what is the FY2015 - FY2017 3 year average net profit margin (as a %) for Best Buy? Answer in units of percents and round to one decimal place.", "gold_answer": "2.8%", "model_answer": "2.8%"}
{"financebench_id": "financebench_id_04417", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the year end FY2019 total amount of inventories for Best Buy? Answer in USD millions. Base your judgments on the information provided primarily in the balance sheet.", "gold_answer": "$5409.00", "model_answer": "The year-end (FY2019) inventories totaled $5,409 million (USD)."}
{"financebench_id": "financebench_id_00685", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Are Best Buy's gross margins historically consistent (not fluctuating more than roughly 2% each year)? If gross margins are not a relevant metric for a company like this, then please state that and explain why.", "gold_answer": "Yes, the margins have been consistent, there has been a minor decline of 1.1% in gross margins between FY2022 and FY2023.", "model_answer": "Short answer: Yes — on a consolidated basis Best Buy’s gross margin has been historically consistent and the year-to‑year changes shown in the filing are within your ~2 percentage‑point threshold. \n\nDetails and context from the Form 10‑K (fiscal years 2021–2023)\n- Consolidated gross profit as a % of revenue:\n  - Fiscal 2021: 22.4%\n  - Fiscal 2022: 22.5%\n  - Fiscal 2023: 21.4%\n  - Year‑to‑year changes: +0.1 percentage point (2021→2022), −1.1 percentage points (2022→2023). Both moves are well within ±2 percentage points.\n\n- Segment detail (for context):\n  - Domestic gross profit %: 22.5% (2021), 22.4% (2022), 21.3% (2023) — similar small movements.\n  - International gross profit %: 21.5% (2021), 23.9% (2022), 23.0% (2023) — this shows a larger swing (≈+2.4 pts from 2021→2022), so some segment‑level variation exceeded the 2% band.\n\nIs gross margin a relevant metric for Best Buy?\n- Yes — gross margin (gross profit as a % of revenue) is a relevant metric for Best Buy. The company reports gross profit rate and discusses drivers (product margin pressure from promotions, services margin changes tied to membership offerings, supply‑chain costs, vendor allowances, profit‑sharing from private‑label/co‑branded cards). Gross margin helps show how product/service pricing, promotions, product mix and vendor funding affect core profitability before operating costs.\n- Caveats to keep in mind:\n  - Best Buy explicitly notes that classification of supply‑chain and related costs between cost of sales and SG&A differs among retailers, so gross‑margin comparisons to other retailers can be misleading.\n  - For a full picture of profitability and operating performance at a retailer, gross margin should be viewed alongside SG&A (operating expenses), operating income margin, and mix shifts (product vs. services, membership effects). For example, Best Buy’s MD&A explains that FY2023’s lower operating margin reflected both a lower gross profit rate and reduced operating leverage from lower sales.\n\nBottom line\n- Consolidated gross margin has been fairly steady (changes < 2 percentage points year‑to‑year for the three fiscal years shown). However, some segment‑level swings (notably International in 2021–2022) exceeded 2 points, and gross margin should be interpreted together with SG&A, operating income and mix changes for a complete view of Best Buy’s performance."}
{"financebench_id": "financebench_id_01077", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are major acquisitions that Best Buy has done in FY2023, FY2022 and FY2021?", "gold_answer": "Best Buy closed two acquisitions, both these companies were already partially owned by Best Buy, but Best Buy acquired all outstanding shares of these two companies during FY 2022: (1) Current Health Ltd and (2) Two Peaks, LLC d/b/a Yardbird Furniture", "model_answer": "Short answer — from Best Buy’s FY2023 Form 10‑K:\n\n- Fiscal 2022 (acquisitions completed during the fiscal year ended Jan 29, 2022):\n  - Current Health Ltd. — acquired Nov. 2, 2021; net cash consideration $389 million; goodwill assigned to Best Buy Health. (See Note 2, “Acquisitions”.)\n  - Two Peaks, LLC (doing business as Yardbird Furniture) — acquired Nov. 4, 2021; net cash consideration $79 million; goodwill assigned to Best Buy Domestic. (See Note 2.)\n\n- Fiscal 2023 (fiscal year ended Jan 28, 2023): No material acquisitions reported in the FY2023 Form 10‑K.\n\n- Fiscal 2021 (fiscal year ended Jan 30, 2021): No material acquisitions disclosed in the FY2023 Form 10‑K for that year.\n\n(References: “Business” section and Note 2 — Acquisitions — in Best Buy’s Form 10‑K for fiscal 2023.)"}
{"financebench_id": "financebench_id_01275", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Best Buy in FY2023?", "gold_answer": "Best Buy generated the most cash flow from operating activities in FY 2023 ($1.8 bn)", "model_answer": "Operating activities. In FY2023 Best Buy reported:\n- Cash provided by operating activities: $1,824 million\n- Cash used in investing activities: $(962) million\n- Cash used in financing activities: $(1,806) million\n\nSo operations brought in the most cash (and the only net source), while investing and financing were net uses."}
{"financebench_id": "financebench_id_00288", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Was there any drop in Cash & Cash equivalents between FY 2023 and Q2 of FY2024?", "gold_answer": "Yes, there was a decline of ~42% between FY2023 and Q2 of FY 2024.", "model_answer": "Yes. Cash and cash equivalents fell from $1,874 million at January 28, 2023 (FY2023 year-end) to $1,093 million at July 29, 2023 (Q2 FY2024) — a decrease of $781 million (about 41.7%).  \n\n(For completeness, total cash, cash equivalents and restricted cash decreased from $2,253 million to $1,491 million — a $762 million decline.)"}
{"financebench_id": "financebench_id_00460", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Was there any change in the number of Best Buy stores between Q2 of FY2024 and FY2023?", "gold_answer": "Yes, there is decline in number stores by 1.32% from 982 stores in Q2 FY 2023 to 969 by the end of Q2 FY2024.", "model_answer": "Yes.\n\n- U.S. Best Buy (large-format) stores: decreased from 930 at the end of Q2 FY2023 to 907 at the end of Q2 FY2024 (down 23 stores).  \n- Canada Best Buy stores: increased from 127 to 128 (up 1 store).\n\nNet global Best Buy store count fell by 22 (1,057 → 1,035)."}
{"financebench_id": "financebench_id_01902", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which Best Buy product category performed the best (by top line) in the domestic (USA) Market during Q2 of FY2024?", "gold_answer": "The entertainment segment experienced the highest growth of 9% during Q2 FY2024, primarily from gaming division.", "model_answer": "Computing and Mobile Phones — $3,674 million of Domestic revenue in Q2 FY2024 (about 41% of Domestic revenue)."}
{"financebench_id": "financebench_id_04660", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Considering the data in the balance sheet, what is Block's (formerly known as Square) FY2016 working capital ratio? Define working capital ratio as total current assets divided by total current liabilities. Round your answer to two decimal places.", "gold_answer": "1.73", "model_answer": "Working capital ratio = Total current assets / Total current liabilities\n\nFrom the consolidated balance sheet (Dec 31, 2016):\n- Total current assets = $1,001,425 thousand\n- Total current liabilities = $577,464 thousand\n\nRatio = 1,001,425 / 577,464 = 1.73 (rounded to two decimal places)."}
{"financebench_id": "financebench_id_07661", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Using the cash flow statement, answer the following question to the best of your abilities: how much did Block (formerly known as Square) generate in cash flow from operating activities in FY2020? Answer in USD millions.", "gold_answer": "$382.00", "model_answer": "Block (Square) generated $381.6 million of cash flow from operating activities in FY2020 (Net cash provided by operating activities: $381,603,000)."}
{"financebench_id": "financebench_id_03838", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2019 - FY2020 total revenue growth rate for Block (formerly known as Square)? Answer in units of percents and round to one decimal place. Approach the question asked by assuming the standpoint of an investment banking analyst who only has access to the statement of income.", "gold_answer": "101.5%", "model_answer": "Using the statement of income totals (Total net revenue: FY2020 = $9,497,578; FY2019 = $4,713,500):\n\nGrowth rate = (9,497,578 − 4,713,500) / 4,713,500 × 100 = 101.5%\n\nAnswer: 101.5%"}
{"financebench_id": "financebench_id_10285", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "We need to calculate a financial metric by using information only provided within the balance sheet. Please answer the following question: what is Boeing's year end FY2018 net property, plant, and equipment (in USD millions)?", "gold_answer": "$12645.00", "model_answer": "Boeing's net property, plant and equipment at year-end FY2018 was $12,645 million (as of December 31, 2018, Consolidated Statements of Financial Position)."}
{"financebench_id": "financebench_id_00517", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Are there any product categories / service categories that represent more than 20% of Boeing's revenue for FY2022?", "gold_answer": "Yes. Boeing has product and service categories that represent more than 20% of Boeing's revenue for FY2022. These categories are Commercial Airplanes which comprises 39% of total revenue, Defence which comprises 35% of total revenue and Services which comprises 26% of total revenue.", "model_answer": "Yes.\n\nFrom Boeing’s FY2022 Form 10‑K (Consolidated Results of Operations / Revenues):\n\n- Commercial Airplanes: $25,867 million — 39% of 2022 revenues  \n- Defense, Space & Security: $23,162 million — 35% of 2022 revenues  \n- Global Services: $17,611 million — 26% of 2022 revenues\n\n(Other: Boeing Capital was $199 million and not >20%.)"}
{"financebench_id": "financebench_id_01091", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has Boeing reported any materially important ongoing legal battles from FY2022?", "gold_answer": "Yes. Multiple lawsuits have been filed against Boeing resulting from a 2018 Lion Air crash and a 2019 Ethiopian Airlines crash.", "model_answer": "Short answer: Yes.\n\nDetails:\n- Boeing disclosed ongoing, potentially material legal matters in FY2022, most notably litigation and government investigations arising from the two 737 MAX accidents (Lion Air Flight 610 and Ethiopian Airlines Flight 302). The company states multiple lawsuits remain pending and that it cannot reasonably estimate the range of loss, if any, not covered by insurance (see Item 3 and Note 21).\n- Related developments in FY2022 reported in the filing include the settlement of an SEC investigation (consent to a civil penalty of $200 million, paid October 2022) and prior agreements reached in 2021 (including the Deferred Prosecution Agreement with the DOJ and a shareholder-derivative settlement that resulted in $219 million received in 2022). Despite those resolutions, the company explicitly notes remaining lawsuits and investigations could still have a material effect.\n- Boeing also disclosed a material arbitration with Embraer arising from Boeing’s 2020 termination of the joint-venture agreements; that dispute is in arbitration and Boeing says it cannot reasonably estimate a range of loss and expects the arbitration to conclude in late 2023 or early 2024 (Note 21).\n\nSource references: Item 3 (Legal Proceedings) and Note 21 to the Consolidated Financial Statements in Boeing’s Form 10-K for the year ended December 31, 2022. \n\nIf you want, I can pull and quote the exact paragraphs from Note 21 that describe the MAX litigation and the Embraer arbitration."}
{"financebench_id": "financebench_id_00678", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Boeing have an improving gross margin profile as of FY2022? If gross margin is not a useful metric for a company like this, then state that and explain why.", "gold_answer": "Yes. Boeing has an improving gross margin profile as of FY2022. Gross profit improved from $3,017 million in FY2021 to $3,502 million in FY2022. Gross margin % improved from 4.8% in FY2021 to 5.3% in FY2022.", "model_answer": ""}
{"financebench_id": "financebench_id_01290", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Who are the primary customers of Boeing as of FY2022?", "gold_answer": "Boeing's primary customers as of FY2022 are a limited number of commercial airlines and the US government. The US government accounted for 40% of Boeing's total revenues in FY2022.", "model_answer": "Boeing’s primary customers in FY2022 were:\n\n- The commercial airline industry worldwide (the main customers of the Commercial Airplanes segment).  \n- Governments (principally the U.S. government, including the U.S. Department of Defense, NASA and related agencies) and other national governments/foreign military sales (the main customers of the Defense, Space & Security segment).  \n- Commercial and government operators and defense customers for aftermarket services (the customers of the Global Services segment).  \n\nKey figures from the 2022 Form 10‑K: about 40% of Boeing’s 2022 revenues were from U.S. government contracts, and non‑U.S. customers (including foreign military sales and commercial airlines outside the U.S.) accounted for approximately 41% of revenues."}
{"financebench_id": "financebench_id_00464", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Is Boeing's business subject to cyclicality?", "gold_answer": "Yes, Boeing's business is subject to cyclicality due to its exposure to the airline industry which is a cyclical industry.", "model_answer": "Short answer: Yes.\n\nSupport from Boeing’s 2022 Form 10‑K:\n- Item 1A (Risk Factors): “Market conditions have a significant impact on demand for our commercial aircraft and related services. … Historically, the airline industry has been cyclical and very competitive and has experienced significant profit swings and constant challenges to be more cost competitive.” (Item 1A, “We depend heavily on commercial airlines…”)  \n- The filing explains demand drivers (economic growth, fuel prices, financing availability, pandemics, geopolitics) and warns that deterioration in economic or airline financial conditions can reduce orders, cause postponements or cancellations and materially affect revenues and backlog.\n- The filing also notes that while Boeing sees supply‑chain, certification and production issues, “No material portion of our business is considered to be seasonal,” distinguishing seasonality from the longer‑term cyclicality described above.\n\nIn short, Boeing’s commercial aircraft business (and therefore the company overall) is exposed to the historical cyclical swings of the airline/commercial aviation market."}
{"financebench_id": "financebench_id_00494", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What production rate changes is Boeing forecasting for FY2023?", "gold_answer": "Boeing forecasts an increase in the production rates for the 737, 777X and 787 aircrafts in 2023.", "model_answer": "Boeing says it expects production to ramp in 2023 as follows:\n\n- 787 — “producing at low rates and we expect to gradually increase to 5 per month in 2023.”  \n- 777X — production was paused and “is expected to resume in 2023.”  \n- 737 — operating around 31 per month (in 2022) and “we plan to gradually increase 737 production rates based on market demand and supply chain capacity.”\n\n(These statements are from Boeing’s 2022 Form 10‑K: discussion of commercial airplane production and program rates.)"}
{"financebench_id": "financebench_id_00585", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How does Boeing's effective tax rate in FY2022 compare to FY2021?", "gold_answer": "Effective tax rate in FY2022 was 0.62%, compared to  -14.76% in FY2021.", "model_answer": "Boeing’s effective tax rate fell sharply — it was −0.6% in FY2022 versus 14.8% in FY2021 (a decrease of 15.4 percentage points)."}
{"financebench_id": "financebench_id_03473", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2017 return on assets (ROA) for Coca Cola? ROA is defined as: FY2017 net income / (average total assets between FY2016 and FY2017). Round your answer to two decimal places. Give a response to the question by relying on the details shown in the balance sheet and the P&L statement.", "gold_answer": "0.01", "model_answer": "Answer: 1.43%\n\nWork shown (from the filing):\n- FY2017 net income attributable to shareowners = $1,248 million (Consolidated Statements of Income).\n- Total assets 12/31/2017 = $87,896 million; total assets 12/31/2016 = $87,270 million (Consolidated Balance Sheets).\n- Average total assets = (87,896 + 87,270) / 2 = 87,583 million.\n- ROA = 1,248 / 87,583 = 0.01425 = 1.43% (rounded to two decimal places)."}
{"financebench_id": "financebench_id_09724", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Coca Cola's FY2021 COGS % margin? Calculate what was asked by utilizing the line items clearly shown in the income statement.", "gold_answer": "39.7%", "model_answer": "COGS % margin (FY2021) = Cost of goods sold / Net operating revenues\n\nFrom the 2021 Consolidated Statement of Income:\n- Net operating revenues = $38,655 million\n- Cost of goods sold = $15,357 million\n\nCalculation:\n15,357 / 38,655 = 0.3975 = 39.75%\n\nAnswer: Coca‑Cola’s FY2021 COGS % margin = 39.75% (≈ 39.8%)."}
{"financebench_id": "financebench_id_06272", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Coca Cola's FY2022 dividend payout ratio (using total cash dividends paid and net income attributable to shareholders)? Round answer to two decimal places. Answer the question asked by assuming you only have access to information clearly displayed in the cash flow statement and the income statement.", "gold_answer": "0.8", "model_answer": "Using the consolidated statements provided:\n\n- Total cash dividends paid (FY2022, from Consolidated Statements of Cash Flows): $7,616 million  \n- Net income attributable to shareowners (FY2022, from Consolidated Statements of Income): $9,542 million\n\nDividend payout ratio = Dividends / Net income = 7,616 / 9,542 = 0.79816 = 79.82%\n\nAnswer: 79.82%"}
{"financebench_id": "financebench_id_10130", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Based on the information provided primarily in the balance sheet and the statement of income, what is FY2020 days payable outstanding (DPO) for Corning? DPO is defined as: 365 * (average accounts payable between FY2019 and FY2020) / (FY2020 COGS + change in inventory between FY2019 and FY2020). Round your answer to two decimal places.", "gold_answer": "63.86", "model_answer": "Calculation\n\n- Average accounts payable = (FY2020 accounts payable + FY2019 accounts payable) / 2\n  = (1,174 + 1,587) / 2 = 1,380.5 (millions)\n\n- FY2020 COGS = 7,772 (millions)\n\n- Change in inventory = Inventory2020 − Inventory2019 = 2,438 − 2,320 = 118 (millions)\n\n- Denominator = FY2020 COGS + change in inventory = 7,772 + 118 = 7,890 (millions)\n\n- DPO = 365 * (average accounts payable) / (denominator)\n  = 365 * 1,380.5 / 7,890 ≈ 63.90 days\n\nAnswer: 63.90 days"}
{"financebench_id": "financebench_id_02981", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Taking into account the information outlined in the income statement, what is the FY2019 - FY2021 3 year average unadjusted operating income % margin for Corning? Answer in units of percents and round to one decimal place.", "gold_answer": "10.3%", "model_answer": "I calculated each year’s operating margin (operating income ÷ net sales) and averaged them:\n\n- 2019: 1,306 / 11,503 = 11.4%  \n- 2020: 509 / 11,303 = 4.5%  \n- 2021: 2,112 / 14,082 = 15.0%\n\nThree-year average (unadjusted) operating income margin = (11.4% + 4.5% + 15.0%) / 3 = 10.3%\n\nAnswer: 10.3%"}
{"financebench_id": "financebench_id_00005", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Corning have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.", "gold_answer": "Yes. Corning had a positive working capital amount of $831 million by FY 2022 close. This answer considers only operating current assets and current liabilities that were clearly shown in the balance sheet.", "model_answer": "Short answer — Yes.\n\nDetails:\n- Working capital (current assets − current liabilities) at December 31, 2022 = $7,453m − $5,175m = $2,278m (the Form 10‑K reports “Working capital $2,278”).\n- Other liquidity context from FY2022: current ratio = 1.4:1; cash & cash equivalents = $1,671m; net cash from operating activities = $2,615m; days sales outstanding ≈ 45; inventories $2,904m (turns 3.4); days payable ≈ 52.\n\nIs working capital a useful metric for Corning?\n- It is a useful, simple indicator of short‑term liquidity — and Corning’s working capital shows current assets comfortably exceed current liabilities at year‑end 2022.\n- However, it has limitations for a large, global manufacturing company like Corning:\n  - It is a snapshot at year‑end and can hide seasonal or timing effects and intra‑year cash flows (Corning reports substantial operating cash generation during the year).\n  - Corning has significant non‑operational and structural items that affect short‑term balances (large amounts of cash held outside the U.S., customer deposits and deferred revenue, and hedging instruments). For example, customer deposits (≈$1.3bn total, ~$132m current) and deferred revenue (≈$869m total, ~$144m current) are meaningful balance‑sheet items that interact with working capital dynamics.\n  - Corning actively uses receivables programs and credit facilities (commercial paper/revolving credit and local liquidity facilities) to manage cash — so measures such as operating cash flow, current ratio, available credit capacity, debt maturities and days‑sales‑outstanding give a more complete picture of liquidity and working‑capital management than the raw working‑capital number alone.\n  \nBottom line: Corning had positive working capital at FY2022 year‑end ($2,278m). That fact is meaningful as a short‑term liquidity indicator, but for a full assessment you should also review operating cash flow, credit lines/available liquidity, customer deposits/deferred revenue, and the Company’s working‑capital trends (DSO, inventory turns, payables) rather than relying on working capital alone."}
{"financebench_id": "financebench_id_01346", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How much has the effective tax rate of Corning changed between FY2021 and FY2022?", "gold_answer": "The effective tax rate of Corning has changed from 20% in FY2021 to 23% in FY 2022.", "model_answer": "Corning’s effective tax rate rose from 20% in FY2021 to 23% in FY2022 — an increase of 3 percentage points (about a 15% relative increase)."}
{"financebench_id": "financebench_id_04209", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Using only the information within the balance sheet, how much total assets did Costco have at the end of FY2021? Answer in USD millions.", "gold_answer": "$59268.00", "model_answer": "Total assets at the end of FY2021: $59,268 million."}
{"financebench_id": "financebench_id_05915", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2018 fixed asset turnover ratio for CVS Health? Fixed asset turnover ratio is defined as: FY2018 revenue / (average PP&E between FY2017 and FY2018). Round your answer to two decimal places. Calculate what was asked by utilizing the line items clearly shown in the P&L statement and the balance sheet.", "gold_answer": "17.98", "model_answer": "I can calculate that, but the excerpt you pasted does not include the Consolidated Statements of Operations or the Consolidated Balance Sheets (where revenue and PP&E are reported). I need the FY2018 total revenue and the PP&E (property, plant & equipment) balances for FY2017 and FY2018 (net of accumulated depreciation) to compute:\n\nFixed asset turnover (FY2018) = FY2018 revenue / ((PP&E at 12/31/2017 + PP&E at 12/31/2018) / 2)\n\nPlease either:\n- Paste the three line items here (FY2018 total revenue; PP&E, net at FY2017 year‑end; PP&E, net at FY2018 year‑end), or\n- Paste the Consolidated Statement of Operations and the Consolidated Balance Sheets from the 10‑K, or\n- Tell me I may look up those numbers and I will fetch them and compute the ratio.\n\nOnce I have those numbers I will compute and round the result to two decimal places."}
{"financebench_id": "financebench_id_00790", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Is CVS Health a capital-intensive business based on FY2022 data?", "gold_answer": "Yes, CVS Health requires an extensive asset base to operate, which is evident from its ROA of only 1.82% in 2022 and 3.39% in 2021, though it should be noted that a significant portion of this asset base is goodwill, and CVS's fixed assets/total assets ratio is on the lower side of 5.6%.", "model_answer": "Short answer: No — not in the way a heavy manufacturer is. By standard capital‑intensity measures CVS’s FY2022 business is relatively asset‑light.\n\nKey FY2022 facts from the 10‑K:\n- Revenues: $322.5 billion.\n- Gross capital expenditures (2022): about $2.7 billion (the 10‑K says “approximately $2.7 billion”). That is ≈0.8% of revenue (2.7 / 322.5).\n- Composition of 2022 capex: ~73% technology/digital/strategic, ~27% store/fulfillment/support facility work.\n- Property & equipment, net: $12.9 billion.\n- Operating lease right‑of‑use assets: $17.9 billion (with related lease liabilities).\n- Inventories: $19.1 billion.\n- Large intangible/goodwill balance (goodwill $78.2 billion) reflecting M&A rather than ongoing heavy capital spending.\n\nWhy that indicates low capital intensity\n- Capital expenditures are small relative to sales (≈0.8% of revenue), far below what you’d see for capital‑intensive industries (utilities, telecom, oil & gas, auto, heavy manufacturing).\n- A substantial portion of the Company’s balance sheet reflects goodwill and operating leases (acquisitions and long‑term store leases) rather than heavy ongoing investment in plant and equipment.\n- The Company is investing heavily in technology/digital (capitalized investment) rather than in large new manufacturing assets.\n\nWhat is capital‑intensive for CVS\n- CVS does carry meaningful lease and store infrastructure obligations (operating lease liabilities ~ $24.0B total per the maturity table) and inventory levels are material; these are working capital / lease commitments rather than high ongoing fixed‑asset investment.\n\nBottom line\nCVS Health operates an asset footprint (stores, distribution/fulfillment centers, clinics and pharmacies) and has sizeable lease and inventory commitments, but its recurring capital expenditure level (≈$2.7B in 2022, mostly technology) is low relative to its revenue. By conventional metrics it is not a highly capital‑intensive business like heavy industry — it is closer to an asset‑light/retail‑and‑services model with significant lease and M&A‑related balance‑sheet items."}
{"financebench_id": "financebench_id_01107", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has CVS Health reported any materially important ongoing legal battles from 2022, 2021 and 2020?", "gold_answer": "Yes, CVS Health has been involved in multiple ongoing legal battles. Some notable legal dispute areas for CVS are: (1) usual and customary pricing litigation: where it's claimed that CVSâs retail pharmacies overcharged for prescription drugs; (2) PBM litigation and investigations: where it's claimed that that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products; and (3) controlled substances litigation: legal matters around opioids for which CVS has agreed to pay up to $4.3 billion to claimants in remediation and $625 million to attorneys and fees", "model_answer": "Short answer: Yes.\n\nDetails and where they’re disclosed in the 2022 Form 10‑K:\n\n- 2022 — Material, company‑level legal charge recorded\n  - CVS recorded $5.8 billion of opioid litigation charges in 2022. The MD&A and segment disclosures explicitly state this charge and point to Note 16 (“Commitments and Contingencies”) for further detail. (See “Segment Analysis” / Corporate/Other discussion and the MD&A discussion citing the $5.8 billion opioid litigation charges.)\n  - The filing also discloses other significant ongoing legal/regulatory matters in 2022 (for example, CMS RADV audits and a DOJ Civil Division investigative demand relating to Medicare risk‑adjustment patient chart review processes). (See the “Government Regulation” and “Risk Factors” sections and the reference to DOJ CIDs.)\n\n- 2021 — Ongoing significant litigation and government audits (but no comparable one‑time charge)\n  - The Company discloses ongoing government audits, investigations and litigation (including RADV audits, False Claims Act/qui tam exposure, opioid and product‑liability litigation such as talc suits) in 2021. These matters are described across the “Risk Factors,” “Government Regulation,” and legal proceedings disclosures. However, the filing does not report a single new charge in 2021 comparable in size to the 2022 opioid charge. (See Item 1A “Risk Factors,” the “Government Regulation” discussion, and Item 3/Note 16 references.)\n\n- 2020 — Ongoing litigation and audits disclosed\n  - The 2020 disclosures likewise describe routine and special audits, False Claims Act / qui tam risk, opioid and product‑liability litigation and other governmental investigations and audits. No single new, materially‑large charge like the 2022 opioid charge was recorded in 2020. (See the same sections referenced above.)\n\nWhere to find the details in the filing\n- Item 3 / “Legal Proceedings” (see cross‑reference to Note 16, “Commitments and Contingencies”).  \n- MD&A / Segment Analysis: specific disclosure of the $5.8 billion opioid litigation charges in 2022 and a pointer to Note 16.  \n- “Government Regulation” and “Risk Factors” sections: discussion of RADV audits, DOJ CIDs and other ongoing investigations and litigation (False Claims Act, qui tam, opioid and talc matters).\n\nConclusion\n- Yes — CVS disclosed materially important ongoing legal battles in its 2022 Form 10‑K. The most material was the opioid litigation in 2022 (the $5.8 billion charge). In 2021 and 2020 the Company disclosed numerous ongoing legal and regulatory matters (DOJ/CMS audits, qui tam/False Claims Act exposure, opioid and product‑liability litigation, etc.), but those years did not include a single newly recorded charge of the magnitude recorded in 2022."}
{"financebench_id": "financebench_id_01244", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has CVS Health paid dividends to common shareholders in Q2 of FY2022?", "gold_answer": "Yes, CVS paid a $ 0.55 dividend per share every quarter in FY2022", "model_answer": "Yes. The 2022 quarterly cash dividend was $0.55 per share, so CVS Health paid a dividend in Q2 FY2022. (From the 10‑K: “During 2022, 2021 and 2020, the quarterly cash dividend was $0.55, $0.50 and $0.50 per share, respectively.”) The consolidated cash‑flow statement also shows dividends paid of $2,907 million for 2022."}
{"financebench_id": "financebench_id_00822", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Were there any board member nominees who had substantially more votes against joining than the other nominees?", "gold_answer": "Yes, his name is Richard A. Johnson", "model_answer": "Yes. Richard A. Johnson received far more “against” votes than the other nominees — 16,105,005 votes against his election. The next-highest against totals were Dona D. Young (6,074,467) and Guillermo G. Marmol (5,753,395); most other nominees had about 4.4–5.2 million against, and Virginia C. Drosos had only 294,935 against."}
{"financebench_id": "financebench_id_00839", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Foot Locker's new CEO have previous CEO experience in a similar company to Footlocker?", "gold_answer": "Yes. She was previous CEO of Ulta Beauty which means she had to manage a large retail company that has brick and mortar + online business. So yes she was a CEO in a similar company to Foot Locker before this.", "model_answer": "Yes. Mary N. Dillon served as Chief Executive Officer of Ulta Beauty from July 2013 through June 2021 — a large omni‑channel specialty retailer — and was also President & CEO of U.S. Cellular (2010–2013). Ulta Beauty is a consumer-facing retail chain, so she has prior CEO experience at a company similar to Foot Locker."}
{"financebench_id": "financebench_id_04103", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2019 cash conversion cycle (CCC) for General Mills? CCC is defined as: DIO + DSO - DPO. DIO is defined as: 365 * (average inventory between FY2018 and FY2019) / (FY2019 COGS). DSO is defined as: 365 * (average accounts receivable between FY2018 and FY2019) / (FY2019 Revenue). DPO is defined as: 365 * (average accounts payable between FY2018 and FY2019) / (FY2019 COGS + change in inventory between FY2018 and FY2019). Round your answer to two decimal places. Address the question by using the line items and information shown within the income statement and the balance sheet.", "gold_answer": "-3.7", "model_answer": "Answer: FY2019 CCC = -3.68 days (rounded to two decimals)\n\nWorkings (using line items in the filing)\n\nInputs from the financial statements\n- FY2019 COGS (Cost of sales): 11,108.4 (Consolidated Statements of Earnings)\n- FY2019 Revenue (Net sales): 16,865.2 (Consolidated Statements of Earnings)\n- Inventories: May 26, 2019 = 1,559.3; May 27, 2018 = 1,642.2 (Consolidated Balance Sheets)\n- Accounts receivable: May 26, 2019 = 1,679.7; May 27, 2018 = 1,684.2 (Consolidated Balance Sheets)\n- Accounts payable: May 26, 2019 = 2,854.1; May 27, 2018 = 2,746.2 (Consolidated Balance Sheets)\n\nAverages and change\n- Average inventory = (1,559.3 + 1,642.2) / 2 = 1,600.75\n- Change in inventory (FY2019 − FY2018) = 1,559.3 − 1,642.2 = −82.9\n- Average accounts receivable = (1,679.7 + 1,684.2) / 2 = 1,681.95\n- Average accounts payable = (2,854.1 + 2,746.2) / 2 = 2,800.15\n- Denominator for DPO = FY2019 COGS + change in inventory = 11,108.4 + (−82.9) = 11,025.5\n\nDays calculations (using the formulas you provided)\n- DIO = 365 * (avg inventory) / (FY2019 COGS)\n  = 365 * 1,600.75 / 11,108.4\n  ≈ 52.60 days\n\n- DSO = 365 * (avg accounts receivable) / (FY2019 Revenue)\n  = 365 * 1,681.95 / 16,865.2\n  ≈ 36.42 days\n\n- DPO = 365 * (avg accounts payable) / (FY2019 COGS + change in inventory)\n  = 365 * 2,800.15 / 11,025.5\n  ≈ 92.70 days\n\nCash Conversion Cycle\n- CCC = DIO + DSO − DPO\n  = 52.60 + 36.42 − 92.70\n  = −3.68 days\n\nTherefore, the FY2019 CCC for General Mills is −3.68 days."}
{"financebench_id": "financebench_id_03471", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "By drawing conclusions from the information stated only in the statement of financial position, what is General Mills's FY2020 working capital ratio? Define working capital ratio as total current assets divided by total current liabilities. Round your answer to two decimal places.", "gold_answer": "0.68", "model_answer": "Working capital ratio = Total current assets / Total current liabilities.\n\nFrom the Consolidated Balance Sheet (May 31, 2020):\nTotal current assets = $5,121.3 million\nTotal current liabilities = $7,491.5 million\n\nWorking capital ratio = 5,121.3 / 7,491.5 = 0.68 (rounded to two decimal places)."}
{"financebench_id": "financebench_id_04854", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "According to the information provided in the statement of cash flows, what is the FY2020 free cash flow (FCF) for General Mills? FCF here is defined as: (cash from operations - capex). Answer in USD millions.", "gold_answer": "$3215.00", "model_answer": "FY2020 free cash flow = $3,215.4 million."}
{"financebench_id": "financebench_id_10136", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "We want to calculate a financial metric. Please help us compute it by basing your answers off of the cash flow statement and the income statement. Here's the question: what is the FY2022 retention ratio (using total cash dividends paid and net income attributable to shareholders) for General Mills? Round answer to two decimal places.", "gold_answer": "0.54", "model_answer": "Retention ratio = (Net income attributable to shareholders - Cash dividends paid) / Net income attributable to shareholders.\n\nFrom the 2022 Form 10‑K:\n- Net earnings attributable to General Mills = $2,707.3 million\n- Dividends paid (cash) = $1,244.5 million\n\nRetention ratio = (2,707.3 − 1,244.5) / 2,707.3 = 1,462.8 / 2,707.3 ≈ 0.540317 ≈ 54.03%\n\nAnswer: 54.03% (FY2022 retention ratio)."}
{"financebench_id": "financebench_id_01484", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How did JnJ's US sales growth compare to international sales growth in FY2022?", "gold_answer": "US sales increased 3.0% vs international sales decline of 0.6%.", "model_answer": "In FY2022 J&J’s U.S. sales increased modestly while international sales were essentially flat on a reported basis but much stronger on an operational basis once currency effects are excluded.\n\n- U.S. reported sales: $48,580M vs $47,156M — +3.0% (operational +3.0%).  \n- International reported sales: $46,363M vs $46,619M — (‑0.6)%; but international operational sales grew ~9.1% (adjusted operational ~9.3%).  \n- FX impact: translational currency was a ~9.7 percentage‑point headwind on international results.\n\nSo: reported U.S. growth (+3.0%) outpaced reported international (slight decline), but on an operational (currency‑adjusted) basis international grew considerably faster (~9% vs 3%)."}
{"financebench_id": "financebench_id_00651", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Is growth in JnJ's adjusted EPS expected to accelerate in FY2023?", "gold_answer": "No, rate of growth in adjusted EPS is expected to decelerate slightly from 3.6% in FY2022 to 3.5% in FY2023.", "model_answer": "No.  In 2022 adjusted diluted EPS was $10.15, up 3.6% year‑over‑year.  For 2023 J&J guides adjusted operational EPS of $10.50 (midpoint), ~3.5% growth — essentially flat-to-slightly lower than 2022.  (If you use the adjusted‑EPS line including currency, the mid‑point implies ~4.0% growth, a small uptick, but the company’s adjusted operational guidance shows no meaningful acceleration.)"}
{"financebench_id": "financebench_id_00669", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.", "gold_answer": "For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment.", "model_answer": "Short answer\n- Johnson & Johnson’s consolidated gross margin slipped about 1.0 percentage point in FY2022 — from ~68.2% in FY2021 to ~67.2% in FY2022 (gross profit $63.92B → $63.85B on sales $93.78B → $94.94B).  \n- The filing attributes the higher cost of products sold (COGS) and the resulting decline in gross margin mainly to: (a) one‑time COVID‑19 vaccine manufacturing exit costs, (b) unfavorable currency impacts in the Pharmaceutical segment, and (c) commodity inflation in MedTech and Consumer Health — partially offset by supply‑chain benefits in Consumer Health.\n\nWhat happened in the numbers (quick view)\n- Sales: $93.775B (2021) → $94.943B (2022) (+1.3%)  \n- Cost of products sold: $29.855B → $31.089B (+~$1.23B)  \n- Gross profit: $63.920B → $63.854B (down about $0.07B)  \n- Gross margin: ~68.2% → ~67.2% (≈100 bps decline)\n\nDrivers called out in the 2022 Form 10‑K\n- One‑time COVID‑19 vaccine manufacturing exit related costs (explicitly cited as increasing COGS).  \n- Currency impacts in the Pharmaceutical segment (negative translation / operational effects).  \n- Commodity inflation impacting MedTech and Consumer Health COGS.  \n- Partially offsetting factors: supply‑chain benefits in Consumer Health (helped COGS) and lower amortization of purchased intangibles (the filing shows intangible amortization in COGS was $4.3B in 2022 vs $4.7B in 2021).\n\nWhy gross margin can be misleading for a diversified company like J&J\n- J&J is a three‑segment healthcare conglomerate (Pharmaceutical, MedTech, Consumer Health). Each segment has very different gross margins and different cost drivers (biologics and specialty pharma tend to have high COGS and pricing dynamics; consumer products have different cost structure; MedTech faces commodity and manufacturing cost swings). Consolidated gross margin therefore mixes very different businesses and can move simply because of mix shifts (e.g., faster growth in a lower‑margin or higher‑margin segment).  \n- One‑time items and acquisition accounting fall into COGS (e.g., the COVID‑19 vaccine exit costs, IPR&D charges, intangible amortization and acquisition‑related adjustments). Those items can materially move consolidated gross margin but are not indicative of underlying operational performance.  \n- Currency translation, government pricing / rebate programs, and reimbursement changes can materially affect consolidated COGS and thus gross margin, and those are often better understood at the segment / product level.\n\nWhat to look at instead (or in addition)\n- Segment gross margins and segment operating income (or “income before tax as a % of sales” by segment) — the 10‑K gives segment income‑before‑tax margins (e.g., 30.3% for Pharmaceuticals, 16.8% for MedTech, 19.6% for Consumer Health in 2022).  \n- Adjusted operating margin or adjusted EBITDA (excluding one‑time vaccination exit costs, impairments, and fair‑value swings) to understand recurring performance.  \n- Product / franchise level trends for large drugs (STELARA, DARZALEX, etc.) and material mix shifts (new launches vs. products facing biosimilars/generics).  \n- Cash gross margin drivers (cash COGS excluding non‑cash amortization and impairments) if you want to see cash operating fundamentals.\n\nBottom line\nThe FY2022 decline in consolidated gross margin was mainly driven by higher COGS (one‑time vaccine exit costs, unfavorable currency in Pharma, and commodity inflation in MedTech/Consumer Health), partially offset by supply‑chain gains in Consumer Health. Because J&J is a diversified healthcare company with significant one‑offs, acquisitions and cross‑segment mix effects, looking at segment margins and adjusted operating measures gives a clearer view of underlying margin performance than consolidated gross margin alone."}
{"financebench_id": "financebench_id_00956", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Are JnJ's FY2022 financials that of a high growth company?", "gold_answer": "No, JnJ's FY2022 financials are not of a high growth company as sales grew by 1.3% in FY2022.", "model_answer": "Short answer: No — Johnson & Johnson’s FY2022 results do not look like those of a “high‑growth” company.\n\nWhy:\n- Revenue growth was essentially flat: consolidated sales rose only 1.3% year‑over‑year to $94.9 billion (volume +6.9%; currency drag −4.8%).\n- Profitability declined: net earnings fell from $20.9B in 2021 to $17.9B in 2022 (diluted EPS $6.73 vs $7.81).\n- Multi‑year growth is modest: 5‑year CAGR for worldwide sales ≈ 4.4%; 10‑year CAGR ≈ 3.5% — consistent with a large, mature company, not a high‑growth business.\n- The company invests heavily in R&D ($14.6B in 2022) and has pockets of strong product-level growth (e.g., DARZALEX, ERLEADA, TREMFYA, some MedTech recovery), but those were insufficient to produce high consolidated revenue growth.\n- Management actions and one‑time items (e.g., COVID‑vaccine exit costs, acquisitions such as Abiomed) also affected 2022 results.\n\nContext: “High growth” typically implies sustained double‑digit top‑line growth or much higher CAGR than J&J’s reported rates; J&J’s 2022 financials are characteristic of a large, diversified, cash‑generating, mature healthcare company with modest organic growth rather than a high‑growth company."}
{"financebench_id": "financebench_id_00711", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Roughly how many times has JnJ sold its inventory in FY2022? Calculate inventory turnover ratio for FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.", "gold_answer": "JnJ sold its inventory 2.7 times in FY2022.", "model_answer": "Summary answer\n- Inventory turnover (FY2022, consolidated) ≈ 31,089 / [(12,483 + 10,387)/2] ≈ 2.7 times.\n- That means Johnson & Johnson turned its inventory roughly 2.7 times in FY2022, or held on average about 365/2.7 ≈ 134 days of inventory.\n\nCalculation (source = J&J 2022 Form 10‑K figures quoted in the filing you supplied)\n- Cost of products sold (FY2022) = $31,089 million (Consolidated Statement of Earnings).\n- Inventories at 1/1/2023 = $12,483 million; inventories at 1/2/2022 = $10,387 million (Consolidated Balance Sheets).\n- Average inventory = (12,483 + 10,387) / 2 = 11,435 million.\n- Inventory turnover = COGS / Average inventory = 31,089 / 11,435 = 2.72 (≈ 2.7 times).\n- Days inventory outstanding ≈ 365 / 2.72 ≈ 134 days.\n\nInterpretation / caveats\n- The consolidated turnover is a simple, correct calculation, but its usefulness is limited for J&J as a whole because the company spans very different businesses (Consumer Health, Pharmaceuticals, MedTech) with very different inventory characteristics:\n  - Consumer products typically have much higher turnover (fast‑moving retail goods).\n  - Pharmaceuticals and MedTech include high‑value finished goods, long manufacturing lead times, regulated inventories, product launch/clinical‑supply stock, and strategic safety stock, all of which tend to lower turnover (raise days on hand).\n  - FY2022 includes acquisition activity (Abiomed closed Dec‑2022) and other supply‑chain effects that can materially affect consolidated inventory balances.\n- Therefore a single consolidated inventory‑turnover ratio can mask large differences by segment and may be of limited meaning for operational benchmarking. For meaningful analysis you should look at turnover (or days) by segment and by product franchise, and consider factors such as product mix, regulatory stock requirements, in‑process/finished goods split and recent acquisitions."}
{"financebench_id": "financebench_id_01487", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Did JnJ's net earnings as a percent of sales increase in Q2 of FY2023 compared to Q2 of FY2022?", "gold_answer": "Yes, net earnings as a percent of sales increased from 20% in Q2 of FY2022 to 20.1% in Q2 of FY2023.", "model_answer": "Yes. Net earnings were 20.1% of sales in Q2 2023 versus 20.0% in Q2 2022 — a 0.1 percentage-point increase (net earnings $5,144M vs $4,814M)."}
{"financebench_id": "financebench_id_01488", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which business segment of JnJ will be treated as a discontinued operation from August 30, 2023 onward?", "gold_answer": "The Consumer Health business segment will be treated as a discontinued operation from August 30, 2023 onward.", "model_answer": "Johnson & Johnson's Consumer Health business — now separated as Kenvue Inc. — will be reported as discontinued operations beginning August 30, 2023."}
{"financebench_id": "financebench_id_01490", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the amount of the gain accruing to JnJ as a result of the separation of its Consumer Health business segment, as of August 30, 2023?", "gold_answer": "JnJ will make a gain of approximately $20 billion from the separation of its Consumer Health business segment.", "model_answer": "Johnson & Johnson recorded a gain of approximately $20 billion related to the separation of its Consumer Health business (Kenvue) in Q3 2023 (as of August 30, 2023)."}
{"financebench_id": "financebench_id_01491", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the amount of the cash proceeds that JnJ realised from the separation of Kenvue (formerly Consumer Health business segment), as of August 30, 2023?", "gold_answer": "JnJ realised $13.2 billion in cash proceeds from the separation of Kenvue.", "model_answer": "Johnson & Johnson reported cash proceeds of $13.2 billion from the separation of Kenvue (via the Kenvue debt offering and IPO) as of August 30, 2023."}
{"financebench_id": "financebench_id_00299", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which of JPM's business segments had the lowest net revenue in 2021 Q1?", "gold_answer": "Corporate. Its net revenue was -$473 million.", "model_answer": "Commercial Banking (CB) — $2,393 million of net revenue in 1Q21."}
{"financebench_id": "financebench_id_02119", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "If JPM went bankrupted by the end by 2021 Q1 and liquidated all of its assets to pay its shareholders, how much could each shareholder get?", "gold_answer": "They could receive $66.56 per share.", "model_answer": "Short answer: about $82.31 per common share (based on the Form 10‑Q figures as of March 31, 2021).\n\nDetails and assumptions\n- Total stockholders’ equity (book value) at 3/31/2021 = $280,714 million (from the filing).  \n- Preferred stock (holders senior to commons) = $31,563 million.  \n- Common stockholders’ equity = $249,151 million (reported).  \n- Common shares outstanding at 3/31/2021 = 3,027,128,112 shares (reported).\n\nIf the company were liquidated and liabilities and preferred claims were paid in full, the residual available to common shareholders would be the common stockholders’ equity:\n 249,151,000,000 / 3,027,128,112 ≈ $82.31 per common share.\n\nNotes / caveats\n- This uses balance-sheet (book) amounts from the 2021 Q1 filing and assumes assets would realize at book value and all liabilities/preferred claims are paid in full. In a real liquidation asset sale prices, liquidation costs, senior claims, taxes, and other adjustments would likely change the outcome.  \n- If you instead divided total stockholders’ equity ($280,714m) by common shares you get ≈ $92.73/share (this would implicitly ignore preferred holders’ senior claim).  \n- If you want the per‑share payout under other assumptions (e.g., net of estimated liquidation costs, or using tangible common equity instead), tell me which and I’ll run the numbers."}
{"financebench_id": "financebench_id_00394", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "In 2022 Q2, which of JPM's business segments had the highest net income?", "gold_answer": "Corporate & Investment Bank. Its net income was $3725 million.", "model_answer": "The Corporate & Investment Bank (CIB) — net income of $3,725 million in 2022 Q2."}
{"financebench_id": "financebench_id_00206", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Are JPM's gross margins historically consistent (not fluctuating more than roughly 2% each year)? If gross margins are not a relevant metric for a company like this, then please state that and explain why.", "gold_answer": "Since JPM is a financial institution, gross margin is not a relevant metric.", "model_answer": "Short answer\n- “Gross margin” is not a meaningful or reported metric for JPMorgan Chase. For banks, investors/management use net interest margin / net yield and other banking-specific metrics (net interest income, overhead ratio, pre‑provision profit, etc.) rather than a traditional “gross margin.”\n- Using the appropriate banking measures from the 2022 Form 10‑K, JPM’s yields/margins (net yield on interest‑earning assets and net yield excluding Markets) have been reasonably stable year‑to‑year — changes are well under a 2 percentage‑point swing in any single year.\n\nWhy “gross margin” isn’t the right metric for a bank\n- “Gross margin” normally means (revenue – cost of goods sold) / revenue for product/manufacturing companies. A bank’s economics are different: the main spread is between interest earned and interest paid (net interest income) and there are large non‑interest revenues and funding/liquidity/capital effects.  \n- JPM’s performance is therefore measured by metrics such as net interest income, net interest yield (net interest margin), noninterest revenue, overhead ratio, ROE/ROTCE, and allowance/charge‑off measures — all of which better capture banking economics and how rates, deposits and loan volumes affect profitability.\n\nRelevant numbers from the 2022 Form 10‑K (managed basis)\n- Net yield on average interest‑earning assets (managed basis): \n  - 2022: 2.00%  \n  - 2021: 1.64%  \n  - 2020: 1.98%  \n  → Year‑to‑year changes: +0.36 percentage points (2021→2022); −0.34 pp (2020→2021). (FTE/managed basis; source: MD&A / “Net interest income, net yield…” table.)\n- Net yield excluding CIB Markets (managed basis): \n  - 2022: 2.60%  \n  - 2021: 1.91%  \n  - 2020: 2.30%  \n  → Year‑to‑year changes: +0.69 pp (2021→2022); −0.39 pp (2020→2021).\n- Overhead ratio (expense / total net revenue): 59% (2022), 59% (2021), 56% (2020) — also fairly stable.\n\nInterpretation\n- Because the filing does not present a “gross margin,” you should not judge JPM by that metric.  \n- The bank‑relevant margins (net yields / net interest income and overhead ratio) have been fairly consistent year‑to‑year; the largest recent movement was driven by changes in interest rates (which increased yields materially in 2022) and market‑driven revenue swings in CIB. These movements are well under a 2 percentage‑point change in the core yield measures (and the overhead ratio stayed essentially flat), so on banking metrics JPM’s margins can be considered reasonably stable over the recent years shown.\n\nIf you want\n- I can pull a short table of the exact line items (net interest income, net interest yield, NIR excluding Markets, overhead ratio, ROE) for 2020–2022 from the filing for easy reference."}
{"financebench_id": "financebench_id_02049", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Looking at VaR, did the risk that JPM faced in the second fiscal quarter of 2023 decrease compared to the same period in the prior year?", "gold_answer": "Yes. It decreased.", "model_answer": "Yes. JPMorgan’s average total VaR for Q2 2023 was $47 million versus $54 million for Q2 2022 (min/max: 36/56 in Q2‑23 vs. 41/71 in Q2‑22). The filing notes the year‑over‑year decrease was driven mainly by reductions in Credit Portfolio VaR and fixed income."}
{"financebench_id": "financebench_id_10499", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Kraft Heinz's FY2019 inventory turnover ratio? Inventory turnover ratio is defined as: (FY2019 COGS) / (average inventory between FY2018 and FY2019). Round your answer to two decimal places. Please base your judgments on the information provided primarily in the balance sheet and the P&L statement.", "gold_answer": "6.25", "model_answer": "Inventory turnover = (FY2019 COGS) / (Average inventory FY2018–FY2019)\n\nFY2019 COGS = $16,830 million (Consolidated Statements of Income)  \nInventory 12/28/2019 = $2,721 million; Inventory 12/29/2018 = $2,667 million (Consolidated Balance Sheets)  \nAverage inventory = (2,721 + 2,667) / 2 = 2,694 million\n\nInventory turnover = 16,830 / 2,694 = 6.247… ≈ 6.25\n\nAnswer: 6.25"}
{"financebench_id": "financebench_id_04412", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "We need to calculate a reasonable approximation (or exact number if possible) of a financial metric. Basing your judgment by information plainly provided in the balance sheet and the P&L statement, what is Lockheed Martin's FY2020 asset turnover ratio? Asset turnover ratio is defined as: FY2020 revenue / (average total assets between FY2019 and FY2020). Round your answer to two decimal places.", "gold_answer": "1.33", "model_answer": "Asset turnover = FY2020 revenue / average total assets (FY2019 & FY2020)\n\n- FY2020 revenue (net sales) = $65,398 million  \n- Total assets 12/31/2020 = $50,710 million  \n- Total assets 12/31/2019 = $47,528 million  \n- Average total assets = (50,710 + 47,528) / 2 = $49,119 million\n\nAsset turnover = 65,398 / 49,119 ≈ 1.33\n\nAnswer: 1.33 (rounded to two decimal places)"}
{"financebench_id": "financebench_id_03031", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Lockheed Martin's FY2021 net working capital? Define net working capital as total current assets less total current liabilities. Answer in USD millions. Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the balance sheet.", "gold_answer": "$5818.00", "model_answer": "As an investment analyst using only the balance sheet figures in the filing and defining net working capital as total current assets less total current liabilities:\n\nTotal current assets (12/31/2021) = $19,815 million\nTotal current liabilities (12/31/2021) = $13,997 million\n\nNet working capital = $19,815m − $13,997m = $5,818 million\n\nLockheed Martin’s FY2021 net working capital: $5,818 million."}
{"financebench_id": "financebench_id_03718", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Lockheed Martin's 2 year total revenue CAGR from FY2020 to FY2022 (in units of percents and round to one decimal place)? Provide a response to the question by primarily using the statement of income.", "gold_answer": "0.4%", "model_answer": "From the Consolidated Statement of Earnings:\n- Net sales FY2020 = $65,398 million\n- Net sales FY2022 = $65,984 million\n\nCAGR (2-year) = (65,984 / 65,398)^(1/2) − 1 = (1.00896)^(0.5) − 1 ≈ 0.00447 = 0.447%\n\nRounded to one decimal place: 0.4% per year."}
{"financebench_id": "financebench_id_04171", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Basing your judgments off of the balance sheet, what is the year end FY2018 amount of accounts payable for MGM Resorts? Answer in USD millions.", "gold_answer": "$303.00", "model_answer": "$302.6 million"}
{"financebench_id": "financebench_id_03849", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2018 - FY2020 3 year average of capex as a % of revenue for MGM Resorts? Answer in units of percents and round to one decimal place. Please utilize information provided primarily within the statement of cash flows and the statement of income.", "gold_answer": "7.9%", "model_answer": "Answer: 7.9%\n\nWork (from the filing):\n- Capex (cash flows — “Capital expenditures, net of construction payable”): 2018 = $1,486,843k; 2019 = $739,006k; 2020 = $270,579k.\n- Net revenues (consolidated statement of operations): 2018 = $11,763,096k; 2019 = $12,899,672k; 2020 = $5,162,082k.\n\nYearly capex / revenue:\n- 2018: 1,486,843 / 11,763,096 = 12.6%\n- 2019: 739,006 / 12,899,672 = 5.7%\n- 2020: 270,579 / 5,162,082 = 5.2%\n\n3‑year average = (12.6% + 5.7% + 5.2%) / 3 = 7.9% (rounded to one decimal place)."}
{"financebench_id": "financebench_id_00382", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which region had the Highest EBITDAR Contribution for MGM during FY2022?", "gold_answer": "Las Vegas resorts contributed ~90% of company level EBITDAR during FY2022.", "model_answer": "Las Vegas Strip Resorts — Adjusted Property EBITDAR of $3,142,308 thousand for FY2022."}
{"financebench_id": "financebench_id_01911", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What was MGM's interest coverage ratio using FY2022 Adjusted EBIT as the numerator and annual Interest Expense as the denominator?", "gold_answer": "As adjusted EBIT is negative, coverage ratio is zero", "model_answer": "Answer: approximately -3.25x\n\nWorkings (Twelve months ended Dec 31, 2022; $ in thousands per the filing):\n- Adjusted EBITDAR = 3,497,254\n- Less: Depreciation & amortization = 3,482,050\n- Less: Triple‑net operating lease & ground lease rent expense = 1,950,566\n=> Adjusted EBIT = 3,497,254 − 3,482,050 − 1,950,566 = −1,935,362\n\n- Interest expense (annual, net of amounts capitalized) = 594,954\n\nInterest coverage ratio = Adjusted EBIT / Interest expense = −1,935,362 / 594,954 ≈ −3.25x\n\n(References: Adjusted EBITDAR and rent reconciliation on page 14; Depreciation & amortization and interest expense on page 11 of the filing.)"}
{"financebench_id": "financebench_id_01912", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which region had the worst topline performance for MGM during FY2022?", "gold_answer": "MGM China experienced the worst topline performance amongst the other regions presented. Its revenue declined 44% in FY2022 whereas the other regions presented increased their revenues.", "model_answer": "MGM China. For FY2022 MGM China reported net revenues of $673.6 million (down 44% year-over-year) — far below Las Vegas Strip Resorts ($8,398.4 million) and Regional Operations ($3,815.9 million) — and an Adjusted Property EBITDAR loss of $203.1 million."}
{"financebench_id": "financebench_id_01254", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has MGM Resorts paid dividends to common shareholders in FY2022?", "gold_answer": "Yes. MGM maintained 0.01$ per share annual dividend through out FY 2022.", "model_answer": "Yes. MGM Resorts paid quarterly common‑stock dividends in 2022 — $0.0025 per share each quarter (four payments), totaling $0.01 per share for the year (about $4 million). See Item 5 (Dividend Policy) and the Cash Flows discussion (payments of $0.0025 per share in March, June, September and December 2022, totaling $4 million)."}
{"financebench_id": "financebench_id_00407", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which type of debt received the largest investment among the short term investments for MGM in H1 FY2023?", "gold_answer": "the biggest short term investment is in corporate bonds (almost 82% of the total investment)", "model_answer": "Corporate bonds — approximately $416.4 million of the short-term investments (416,420 in the filing, in thousands) as of H1 FY2023."}
{"financebench_id": "financebench_id_04700", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2016 COGS for Microsoft? Please state answer in USD millions. Provide a response to the question by primarily using the statement of income.", "gold_answer": "$32780.00", "model_answer": "FY2016 cost of goods sold (Cost of revenue): $32,780 million (per the consolidated income statement, Year Ended June 30, 2016)."}
{"financebench_id": "financebench_id_00552", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has Microsoft increased its debt on balance sheet between FY2023 and the FY2022 period?", "gold_answer": "No. Microsoft decreased its debt by $2.5bn in FY 2023 vs FY 2022.", "model_answer": "No. Microsoft’s total reported debt decreased.\n\n- Total debt (current portion + long-term) was $49,781 million as of June 30, 2022 and $47,237 million as of June 30, 2023 — a decrease of $2,544 million (≈ $2.54 billion). (See Note 11 — Debt and the consolidated balance sheets.)\n- Breakdown: current portion of long-term debt rose from $2,749 million (2022) to $5,247 million (2023), while long-term debt fell from $47,032 million (2022) to $41,990 million (2023)."}
{"financebench_id": "financebench_id_04458", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "We want to calculate a financial metric. Please help us compute it by basing your answers off of the statement of income and the statement of cash flows. Here's the question: what is the FY2015 unadjusted EBITDA % margin for Netflix? Calculate unadjusted EBITDA using unadjusted operating income and D&A (from cash flow statement).", "gold_answer": "5.4%", "model_answer": "Answer (FY2015, unadjusted EBITDA % margin)\n\nCalculations (all $ in thousands, per the 2015 Form 10‑K):\n- Operating income (unadjusted): 305,826 (Consolidated Statements of Operations)  \n- Depreciation & amortization (from cash flow statement, “Depreciation and amortization of property, equipment and intangibles”): 62,283 (Consolidated Statements of Cash Flows)  \n- Unadjusted EBITDA = 305,826 + 62,283 = 368,109  \n- Revenues (2015): 6,779,511  \n- Unadjusted EBITDA margin = 368,109 / 6,779,511 = 0.05431 ≈ 5.43%\n\nResult: FY2015 unadjusted EBITDA margin ≈ 5.4% (based on operating income + D&A as shown in the cash flow statement).\n\nNote: If you intended to include content amortization (streaming + DVD amortization) in “D&A,” the EBITDA and margin would be very different (much higher); confirm if you want that alternative measure."}
{"financebench_id": "financebench_id_03282", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is Netflix's year end FY2017 total current liabilities (in USD millions)? Base your judgments on the information provided primarily in the balance sheet.", "gold_answer": "$5466.00", "model_answer": "Netflix's total current liabilities at year-end FY2017 were $5,466.3 million (reported as $5,466,312 thousand on the Consolidated Balance Sheet)."}
{"financebench_id": "financebench_id_04302", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "We need to calculate a reasonable approximation (or exact number if possible) of a financial metric. Basing your judgment by information plainly provided in the statement of income, what is Nike's three year average of cost of goods sold as a % of revenue from FY2016 to FY2018? Answer in units of percents and round to one decimal place.", "gold_answer": "55.1%", "model_answer": "NIKE’s COGS (% of revenue) by year:\n- FY2018: 100% − 43.8% gross margin = 56.2%\n- FY2017: 100% − 44.6% gross margin = 55.4%\n- FY2016: 100% − 46.2% gross margin = 53.8%\n\nThree‑year average (FY2016–FY2018) = (56.2% + 55.4% + 53.8%)/3 = 55.1% (rounded to one decimal place)."}
{"financebench_id": "financebench_id_03531", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "According to the details clearly outlined within the balance sheet, how much total current assets did Nike have at the end of FY2019? Answer in USD millions.", "gold_answer": "$16525.00", "model_answer": "Total current assets at the end of FY2019: USD 16,525 million."}
{"financebench_id": "financebench_id_04080", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "When primarily referencing the income statement and the statement of financial position, what is the FY2021 inventory turnover ratio for Nike? Inventory turnover ratio is defined as: (FY2021 COGS) / (average inventory between FY2020 and FY2021). Round your answer to two decimal places.", "gold_answer": "3.46", "model_answer": "Inventory turnover = FY2021 COGS / average inventory (FY2020 & FY2021)\n\nFY2021 COGS = $24,576 million\nInventories at 5/31/2021 = $6,854 million\nInventories at 5/31/2020 = $7,367 million\nAverage inventory = (6,854 + 7,367) / 2 = $7,110.5 million\n\nInventory turnover = 24,576 / 7,110.5 = 3.4563 ≈ 3.46\n\nAnswer: 3.46 times."}
{"financebench_id": "financebench_id_01163", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Nike in FY2023?", "gold_answer": "Among the three, cash flow from operations was the highest for Nike in FY2023.", "model_answer": "Operating activities — they provided the most cash in FY2023: +$5,841 million.  \nInvesting activities also provided cash: +$564 million.  \nFinancing activities were a use of cash: −$7,447 million."}
{"financebench_id": "financebench_id_00080", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Paypal have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.", "gold_answer": "Yes. Paypal has a positive working capital of $ 1.6Bn as of FY2022 end.", "model_answer": "Short answer\nYes — on a GAAP basis PayPal had positive working capital at December 31, 2022: current assets $57,517 million minus current liabilities $45,101 million = positive working capital of $12,416 million (≈ $12.4 billion).\n\nWhy that number can be misleading for PayPal\nPayPal is a payments platform that holds large customer balances and processes funds in transit. Its consolidated current assets and current liabilities include large, offsetting custodial items:\n\n- Funds receivable and customer accounts (current asset): $36,357 million\n- Funds payable and amounts due to customers (current liability): $40,107 million\n\nBecause these items are customer funds held in custody or amounts in transit (and in many jurisdictions subject to regulatory restrictions), they do not represent freely available corporate liquidity. The Form 10‑K explicitly notes that not all cash is available for general corporate purposes and that certain customer balances must be maintained in eligible liquid assets.\n\nBetter ways to evaluate PayPal’s near‑term liquidity\nFor payment companies, the simple working‑capital number (current assets − current liabilities) is of limited usefulness. Preferred measures include:\n\n- Cash and investments available for corporate use (i.e., excluding funds held on behalf of customers). PayPal reports “cash, cash equivalents, and investments” (excluding assets related to funds receivable and customer accounts) of $13,723 million at 12/31/2022. Compare that to current liabilities excluding amounts due to customers:\n  - Current liabilities total $45,101 million − funds payable $40,107 million = $4,994 million.\n  - “Corporate” cash & investments $13,723m − corporate current liabilities $4,994m ≈ $8,729 million of liquidity available to the business.\n- Operating cash flow (annual cash from operations): $5,813 million for 2022 (from the statement of cash flows).\n- Net debt and available credit facilities (notes and revolvers) and regulatory capital measures for regulated subsidiaries.\n\nConclusion\nQuantitatively, PayPal’s GAAP working capital at FY2022 is positive (~$12.4B). Qualitatively, that headline working‑capital figure is not a very useful indicator of PayPal’s operating liquidity because it is dominated by customer funds and funds‑in‑transit that are not available for general corporate use. For a more meaningful view of PayPal’s liquidity, look at cash and investments excluding customer balances, operating cash flow, net debt, and available committed credit."}
{"financebench_id": "financebench_id_04980", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2021 capital expenditure amount (in USD billions) for PepsiCo? Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the statement of cash flows.", "gold_answer": "$4.60", "model_answer": "Using only the Consolidated Statement of Cash Flows, PepsiCo’s FY2021 capital spending (capex) is reported as $4,625 million — i.e., $4.625 billion."}
{"financebench_id": "financebench_id_03620", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2022 unadjusted EBITDA less capex for PepsiCo? Define unadjusted EBITDA as unadjusted operating income + depreciation and amortization [from cash flow statement]. Answer in USD millions. Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the statement of cash flows and the income statement.", "gold_answer": "$9068.00", "model_answer": "Answer (FY2022, USD millions) — analyst view using only the Income Statement and Statement of Cash Flows:\n\n- Reported operating profit (unadjusted operating income) — Consolidated Statement of Income (FY 2022): $11,512\n- Depreciation & amortization — Consolidated Statement of Cash Flows (FY 2022): $2,763\n\nUnadjusted EBITDA = 11,512 + 2,763 = $14,275\n\n- Capital spending (capex) — Consolidated Statement of Cash Flows (FY 2022): $5,207\n\nUnadjusted EBITDA less capex = 14,275 − 5,207 = $9,068\n\nFinal answer: $9,068 million."}
{"financebench_id": "financebench_id_00735", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has Pepsico reported any materially important ongoing legal battles from FY2022 and FY2021?", "gold_answer": "No, Pepsico is not involved in material legal battles.", "model_answer": "Short answer: No.\n\nPepsiCo’s Form 10‑K (fiscal 2022) discloses that the company “and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations,” but does not identify any individual matter as a materially important ongoing legal battle. Management states (Item 3. Legal Proceedings) that “management believes that the final outcome of the foregoing will not have a material adverse effect on our financial condition, results of operations or cash flows.” The filing similarly discusses legal/regulatory risk generally (see Item 1 – Regulatory Matters and Item 1A – Risk Factors) but no specific material litigation from FY2022 or FY2021 is reported as expected to be material. (See Item 3, “Legal Proceedings,” and related disclosures in Item 1 and Item 1A.)"}
{"financebench_id": "financebench_id_01328", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the quantity of restructuring costs directly outlined in Pepsico's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.", "gold_answer": "Pepsico's restructuring costs in FY2022 amounted to $411 million .", "model_answer": "0\n\nPepsiCo’s consolidated statement of income for 2022 does not show a line item labeled “restructuring costs.” (Note: the company does disclose “res\n\ntructuring and impairment charges” in Note 3 totaling $411 million pre‑tax for 2022, but restructuring costs are not an explicit line item in the income statement itself.)"}
{"financebench_id": "financebench_id_01009", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are the geographies that Pepsico primarily operates in as of FY2022?", "gold_answer": "As of FY2022, Pepsico primarily operates in the following geographies: North America, Latin America, Europe, Africa, Middle East, South Asia, Asia Pacific, Australia, New Zealand and China.", "model_answer": "PepsiCo’s primary operating geographies (its seven reportable segments) in FY2022 were:\n\n- Frito‑Lay North America (United States and Canada)  \n- Quaker Foods North America (United States and Canada)  \n- PepsiCo Beverages North America (United States and Canada)  \n- Latin America (LatAm)  \n- Europe  \n- Africa, Middle East & South Asia (AMESA)  \n- Asia Pacific, Australia & New Zealand and China region (APAC)"}
{"financebench_id": "financebench_id_04481", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2022 unadjusted EBITDA % margin for PepsiCo? Calculate unadjusted EBITDA using unadjusted operating income and D&A (from cash flow statement). Give a response to the question by relying on the details shown in the statement of cash flows and the P&L statement.", "gold_answer": "16.5%", "model_answer": "Using the amounts reported in the filing:\n\n- Operating profit (GAAP operating income), FY2022 (Consolidated Statement of Income): $11,512 million  \n- Depreciation & amortization, FY2022 (Consolidated Statement of Cash Flows, “Depreciation and amortization”): $2,763 million\n\nUnadjusted EBITDA = Operating profit + D&A\n= $11,512m + $2,763m = $14,275 million\n\nNet revenue, FY2022 (Consolidated Statement of Income): $86,392 million\n\nUnadjusted EBITDA margin = Unadjusted EBITDA / Net revenue\n= $14,275m / $86,392m = 0.16535 ≈ 16.54%\n\nAnswer: FY2022 unadjusted EBITDA ≈ $14,275 million, which is about a 16.5% unadjusted EBITDA margin (based on the reported operating profit and D&A in the filing)."}
{"financebench_id": "financebench_id_01474", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "As of FY2023Q1, why did Pepsico raise full year guidance for FY2023?", "gold_answer": "Pepsico experienced a strong start to FY2023.", "model_answer": "PepsiCo raised its FY2023 guidance because of a stronger-than-expected start to the year — resilient categories and geographies and strong business momentum in Q1. Key Q1 facts cited in the filing: organic revenue grew 14.3% and core constant‑currency EPS rose 18%. Management said those results (and the payoff from investments under its “Winning with pep+” agenda) gave them confidence to increase full‑year organic revenue guidance from 6% to 8% and core constant‑currency EPS guidance from 8% to 9% (implying core EPS of $7.27)."}
{"financebench_id": "financebench_id_01476", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "As of FY2023Q1, by how many percentage points did Pepsico raise full year guidance in respect of core constant currency EPS growth?", "gold_answer": "Pepsico raised full year guidance in respect of core constant currency EPS growth by 1 percentage point.", "model_answer": "PepsiCo raised its full-year core constant currency EPS growth guidance from 8% to 9% — an increase of 1 percentage point."}
{"financebench_id": "financebench_id_01482", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "At the Pepsico AGM held on May 3, 2023, what was the outcome of the shareholder vote on the shareholder proposal for a congruency report by Pepsico on net-zero emissions policies?", "gold_answer": "The shareholder proposal for a congruency report by Pepsico on net-zero emissions policies was defeated.", "model_answer": "The proposal was defeated. Vote tally: For 19,718,780; Against 977,228,788; Abstain 23,200,321; Broker non-votes 172,969,325."}
{"financebench_id": "financebench_id_00705", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "By how much did Pepsico increase its unsecured five year revolving credit agreement on May 26, 2023?", "gold_answer": "$400,000,000 increase.", "model_answer": "PepsiCo increased its five-year unsecured revolving credit agreement by $400,000,000 — from $3,800,000,000 to $4,200,000,000."}
{"financebench_id": "financebench_id_00882", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "As of May 26, 2023, what is the total amount Pepsico may borrow under its unsecured revolving credit agreements?", "gold_answer": "Total amount Pepsico may borrow under unsecured revolving credit agreements = $8,400,000,000.", "model_answer": "PepsiCo entered two new unsecured revolvers on May 26, 2023 — a $4.2 billion 364‑day facility and a $4.2 billion five‑year facility — so the combined available amount is $8.4 billion. (Each facility can later be increased to $4.95 billion, which would raise the combined maximum to $9.9 billion.)"}
{"financebench_id": "financebench_id_02416", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are three main companies acquired by Pfizer mentioned in this 10K report?", "gold_answer": "Trillium, Array, and Therachon", "model_answer": "Three companies mentioned as acquisitions in the filing:\n\n- Trillium (acquired November 2021) — a clinical‑stage immuno‑oncology company.  \n- Arena (definitive agreement announced December 2021; shareholder approval February 2, 2022) — a clinical‑stage company focused on immuno‑inflammatory diseases.  \n- Array BioPharma (acquired July 2019) — a commercial/clinical‑stage biopharma with oncology assets (e.g., Braftovi/Mektovi)."}
{"financebench_id": "financebench_id_00702", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Were there any potential events that are not in Pfizer's standard business operations that substantially increased net income in 2019?", "gold_answer": "Yes, the gain on completion of Consumer Healthcare JV Transaction", "model_answer": "Yes.\n\nThe material, non‑operating item that substantially increased Pfizer’s 2019 net income was the gain on completion of the Consumer Healthcare joint venture with GSK.  When the JV closed in July 2019 Pfizer received a 32% equity stake and recorded a pre‑tax gain of about $8.1 billion (reported as “(Gain) on completion of Consumer Healthcare JV transaction” in the 2019 income statement), which was roughly $5.4 billion after tax—a major contributor to 2019’s net income. (See Consolidated Statements of Income and the MD&A discussion of the Consumer Healthcare JV.)\n\nIn addition, Pfizer recorded favorable tax items in 2019 (including benefits related to the favorable settlement of an IRS audit and related items) that further reduced tax expense and boosted net income in that year (disclosed in the tax note/reconciliation)."}
{"financebench_id": "financebench_id_00302", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Did Pfizer grow its PPNE between FY20 and FY21?", "gold_answer": "Yes, change in PPNE was positive year over year", "model_answer": "Yes. Pfizer’s net property, plant and equipment (PPNE) increased from $13,745 million at year-end 2020 to $14,882 million at year-end 2021 — an increase of $1,137 million (about 8.3%) (see Note 9)."}
{"financebench_id": "financebench_id_00283", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "How much does Pfizer expect to pay to spin off Upjohn in the future in USD million?", "gold_answer": "77.78", "model_answer": "Pfizer said it expects total separation costs of about $700 million related to Upjohn. About 90% (~$630 million) has already been incurred, leaving roughly $70 million expected to be paid in the future."}
{"financebench_id": "financebench_id_00724", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "For Pfizer, which geographic region had the biggest drop in Q22023 year over year revenues (on a percentage basis)?", "gold_answer": "Developed Rest of the World", "model_answer": "Developed Rest of World — revenues fell 74% year-over-year (Q2 2023 $1,305M vs Q2 2022 $5,034M)."}
{"financebench_id": "financebench_id_02419", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "As of Q2'2023, is Pfizer spinning off any large business segments?", "gold_answer": "Yes, it's spinning off Upjohn.", "model_answer": "No. As of the quarter ended July 2, 2023 Pfizer was not spinning off any large business segment.\n\nSupport from the filing:\n- The Upjohn Business was already spun off on November 16, 2020 (Defined Terms: “Upjohn Business … was spun-off on November 16, 2020 and combined with Mylan to create Viatris”).  \n- The consumer‑health joint venture was demerged in July 2022 (Note 2C: “On July 18, 2022, GSK completed a demerger … we continue to own 32% of the ordinary shares of Haleon”). Pfizer therefore holds a 32% equity investment in Haleon rather than spinning it off in Q2 2023.  \n- MD&A notes separation-related costs remaining for Upjohn (ongoing costs through Q2 2023), but does not describe any new or ongoing spin‑off of a large business segment in Q2 2023.\n\n(There are other corporate actions discussed—e.g., the proposed Seagen acquisition and, after quarter‑end, a July 2023 agreement to sell an early‑stage gene‑therapy portfolio to Alexion—but no Q2 2023 spin‑off of a large business segment is reported.)"}
{"financebench_id": "financebench_id_00605", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What percent of Ulta Beauty's total spend on stock repurchases for FY 2023 occurred in Q4 of FY2023?", "gold_answer": "36%. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.", "model_answer": "Q4 repurchases were $328.1M of the $900.0M repurchased in FY2023.\n\n328.1 / 900.0 = 0.3646 → about 36.5% of the fiscal year repurchases occurred in Q4."}
{"financebench_id": "financebench_id_00606", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Did Ulta Beauty's wages expense as a percent of net sales increase or decrease in FY2023?", "gold_answer": "Wages expense as a percent of net sales increased in FY2023. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.", "model_answer": "Increased.\n\nThe filing notes that store payroll and benefits \"deleverage[d] ... due to wage investments\" (mentioned in both the fourth-quarter and full-year discussions), indicating wages increased as a percent of net sales."}
{"financebench_id": "financebench_id_00603", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove the increase in Ulta Beauty's merchandise inventories balance at end of FY2023?", "gold_answer": "Increase in Merchandise inventories balance was driven by the opening of 47 new stores. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.", "model_answer": "Ulta’s merchandise inventories rose about $104.2 million year‑over‑year (to $1,603.5M at Jan 28, 2023). Management said the increase was primarily driven by inventory for 47 new stores opened during fiscal 2022, inventory to support new brand launches and brand expansions, and higher inventory costs."}
{"financebench_id": "financebench_id_00601", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What drove the reduction in SG&A expense as a percent of net sales in FY2023?", "gold_answer": "Lower marketing expenses and leverage of incentive compensation due to higher sales. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.", "model_answer": "The filing states that SG&A (which rose in dollars to $2,395.3M but fell as a percent of sales to 23.5% from 23.9%) was primarily reduced by lower marketing expenses and leverage of incentive compensation due to higher sales. These savings were partially offset by deleverage from increased corporate overhead (strategic investments) and higher store payroll and benefits from wage investments.\n\n(Note: the results are for the fiscal year ended Jan 28, 2023 — presented as fiscal 2022 in the filing.)"}
{"financebench_id": "financebench_id_00746", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Which debt securities are registered to trade on a national securities exchange under Ulta Beauty's name as of FY2023?", "gold_answer": "There are none", "model_answer": "None. Ulta Beauty has no debt securities registered on a national securities exchange as of fiscal 2023 — only its common stock (ULTA) is listed (NASDAQ Global Select Market)."}
{"financebench_id": "financebench_id_00521", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What are major acquisitions that Ulta Beauty has done in FY2023 and FY2022?", "gold_answer": "Ulta Beauty did not make any acquisitions in FY2023 and FY2022.", "model_answer": "Short answer: Ulta Beauty did not complete any material acquisitions in fiscal 2023 or fiscal 2022.\n\nSupport from the 10‑K you provided:\n- Consolidated Statements of Cash Flows (Fiscal years ended Jan. 28, 2023; Jan. 29, 2022; Jan. 30, 2021) shows “Acquisitions, net of cash acquired” as — for 2023, — for 2022, and $(1,220) for 2021 (i.e., a small acquisition in FY2021 only).  \n- The Goodwill note (Note 7) shows no acquisitions recorded in fiscal 2023 or 2022 (Goodwill beginning and ending balances unchanged).\n\nTherefore, there were no major (or material) acquisitions in FY2023 or FY2022 according to the filing."}
{"financebench_id": "financebench_id_00859", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Among all of the derivative instruments that Verizon used to manage the exposure to fluctuations of foreign currencies exchange rates or interest rates, which one had the highest notional value in FY 2021?", "gold_answer": "Cross currency swaps. Its notional value was $32,502 million.", "model_answer": "Cross-currency swaps — $32.5 billion notional (as of December 31, 2021).\n\nThis is the largest notional amount among Verizon’s derivatives used to manage foreign‑currency or interest‑rate exposure in FY2021 (see Item 7A/Note 9)."}
{"financebench_id": "financebench_id_02024", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "As of FY 2021, how much did Verizon expect to pay for its retirees in 2024?", "gold_answer": "The estimated pension benefits were $1097 million, and the estimated health care and life insurance benefits were $862 million.", "model_answer": "Verizon expected to pay $1,959 million in 2024 — $1,097 million for pension benefits and $862 million for health care and life benefits (total ≈ $1.959 billion)."}
{"financebench_id": "financebench_id_00216", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Does Verizon have a reasonably healthy liquidity profile based on its quick ratio for FY 2022? If the quick ratio is not relevant to measure liquidity, please state that and explain why.", "gold_answer": "No. The quick ratio was approximately 0.54 for Verizon. It indicated that Verizon does not have a healthy liquidity profile.", "model_answer": "Short answer\n- Quick ratio (acid-test) for Verizon at 12/31/2022 ≈ 0.71 (35,469 / 50,171). By the textbook rule of thumb (<1) that would suggest current liabilities exceed readily liquid current assets.\n- However, the quick ratio is of limited usefulness for a large, capital‑intensive telecom like Verizon. Despite the <1 quick ratio, Verizon’s liquidity profile is reasonably healthy when you consider its recurring operating cash flow, free cash flow generation, available committed credit, asset-backed financing capacity and access to the capital markets.\n\nHow I calculated the quick ratio\n- Current assets (12/31/2022) = $37,857 million\n- Less inventories = $2,388 million\n- Quick assets = 37,857 − 2,388 = $35,469 million\n- Current liabilities (12/31/2022) = $50,171 million\n- Quick ratio = 35,469 / 50,171 ≈ 0.71\n\nWhy the quick ratio understates Verizon’s practical liquidity\n- The quick ratio is a narrow, point‑in‑time measure that focuses on cash, receivables and equivalents vs. current liabilities. It does not reflect:\n  - Very large and predictable operating cash generation (2022 cash flows from operations = $37.1 billion; free cash flow in 2022 = $14.05 billion).\n  - Access to committed financing and capital markets. Verizon had an unused revolving credit facility capacity (~$9.4 billion) and other export credit facilities available (see Form 10‑K Liquidity section).\n  - Asset‑backed financing programs that sponsor receivables and provide borrowing capacity (Verizon’s consolidated asset‑backed debt program and related facilities).\n  - The company’s practical ability to refinance short‑term maturities in capital markets (Verizon is an investment‑grade issuer with ongoing access to long‑term debt issuance).\n- Telecoms are capital‑intensive with predictable cash flows and relatively low inventory levels; therefore liquidity is better assessed by operating cash flow, free cash flow, committed credit lines and the near‑term debt maturity schedule rather than a single quick ratio snapshot.\n\nRelevant facts from the 2022 Form 10‑K that support a reasonably healthy liquidity position\n- Cash and cash equivalents (12/31/2022): $2.605 billion; restricted cash brings consolidated cash + restricted cash to ~$4.11 billion.\n- Operating cash flow (2022): $37.141 billion; free cash flow (2022): $14.054 billion (operating cash flow − capex).\n- Unused borrowing capacity: $9.436 billion under the revolving credit facility (per 10‑K).\n- Asset‑backed debt program in place (carrying value $20.0 billion at year end) and ABS financing facilities that provide funding tied to receivables.\n- Total debt outstanding was large (~$150.6 billion) but Verizon has demonstrated ongoing access to debt markets (issued bonds and asset‑backed debt in 2022) and manages maturities (long maturity profile, use of swaps, etc.).\n\nConclusion / practical view\n- If you judge liquidity only by the quick ratio, Verizon’s quick ratio (~0.71) is below the conservative 1.0 benchmark and could be viewed as weak.\n- In practice, for Verizon the quick ratio alone is not the best gauge. Considering strong and predictable operating cash flow, substantial free cash flow, available committed credit, active asset‑backed financing programs and demonstrated capital market access, Verizon’s liquidity profile for FY 2022 appears reasonably healthy and adequate to meet near‑term obligations.\n- For a fuller assessment, focus on: operating cash flow and free cash flow trends, cash + committed credit lines, near‑term debt maturities and interest coverage ratios rather than relying solely on the quick ratio."}
{"financebench_id": "financebench_id_00215", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Is Verizon a capital intensive business based on FY 2022 data?", "gold_answer": "Yes. Verizon's capital intensity ratio was approximately 2.774729. This means that it took approximately $2.77 of assets to generate $1 of revenue and thus, Verizon can be considered capital intensive.", "model_answer": "Yes — Verizon is a capital‑intensive business in FY2022.\n\nKey facts from the 2022 Form 10‑K that support this conclusion\n- Large ongoing capital spending: Capital expenditures (including capitalized software) were $23.087 billion in 2022 — about $23.1B.  \n  - As a share of revenue: $23.087B / $136.835B ≈ 16.9% of 2022 revenue (≈17%).  \n  - Relative to cash‑profit measure: CapEx / Consolidated Adjusted EBITDA ($47,870M) ≈ 48% (capex consumed ~half of adjusted EBITDA).\n- Asset‑heavy balance sheet: total gross investment in property, plant & equipment ≈ $308 billion (before accumulated depreciation) at 12/31/2022; PP&E, net ≈ $107.4B. Network equipment is ~77% of that gross PP&E.  \n- Very large spectrum (indefinite‑lived intangible) assets: wireless licenses carrying value ≈ $149.8 billion at 12/31/2022; Verizon made very large spectrum purchases in recent years (C‑Band).  \n- Depreciation & amortization: $17.099B in 2022 — capex exceeded D&A, indicating continued heavy reinvestment in the networks.  \n- Industry context / disclosures: MD&A repeatedly describes the business strategy as requiring “significant capital investments” to acquire spectrum, build/upgrade 4G/5G and fiber networks, densify sites, etc.; 2022 noted as a peak year for C‑Band deployment.\n\nTaken together: high, recurring capex, very large PP&E and spectrum carrying amounts, and capex that is a large fraction of operating cash flow/EBITDA demonstrate that Verizon’s business is capital‑intensive in FY2022."}
{"financebench_id": "financebench_id_00566", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Has Verizon increased its debt on balance sheet between 2022 and the 2021 fiscal period?", "gold_answer": "No. Verizon's debt decreased by $229 million.", "model_answer": "No. Verizon’s total debt slightly decreased — from $150.9 billion at December 31, 2021 to $150.6 billion at December 31, 2022 (total debt reported as $150,868M in 2021 vs. $150,639M in 2022).  \n(Note: short-term debt rose from $7.4B to $9.96B, while long-term debt fell from $143.4B to $140.7B.)"}
{"financebench_id": "financebench_id_06247", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is FY2018 days payable outstanding (DPO) for Walmart? DPO is defined as: 365 * (average accounts payable between FY2017 and FY2018) / (FY2018 COGS + change in inventory between FY2017 and FY2018). Round your answer to two decimal places. Please base your judgments on the information provided primarily in the statement of financial position and the P&L statement.", "gold_answer": "42.69", "model_answer": "FY2018 DPO = 365 * (average accounts payable) / (FY2018 COGS + change in inventory)\n\nFrom the Form 10‑K (all $ amounts in millions):\n- Accounts payable: Jan 31, 2018 = 46,092; Jan 31, 2017 = 41,433 → average AP = (46,092 + 41,433) / 2 = 43,762.50\n  (Consolidated Balance Sheets)\n- FY2018 Cost of sales (COGS) = 373,396 (Consolidated Statements of Income)\n- Inventories: Jan 31, 2018 = 43,783; Jan 31, 2017 = 43,046 → change in inventory = 43,783 − 43,046 = 737\n\nDenominator = COGS + change in inventory = 373,396 + 737 = 374,133\n\nNumerator = 365 * average AP = 365 * 43,762.50 = 15,973,312.50\n\nDPO = 15,973,312.50 / 374,133 = 42.69 days (rounded to two decimals)\n\nAnswer: 42.69 days"}
{"financebench_id": "financebench_id_04784", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "Based on the information provided primarily in the statement of income, what is the FY2018 - FY2019 change in unadjusted operating income % margin for Walmart? Answer in units of percents and round to one decimal place.", "gold_answer": "0.2%", "model_answer": "+0.2%"}
{"financebench_id": "financebench_id_06741", "model_name": "gpt-5-mini", "eval_mode": "inContext", "temp": null, "question": "What is the FY2018 - FY2020 3 year average unadjusted EBITDA % margin for Walmart? Define unadjusted EBITDA as unadjusted operating income + depreciation and amortization from the cash flow statement. Answer in units of percents and round to one decimal place. Calculate what was asked by utilizing the line items clearly shown in the P&L statement and the cash flow statement.", "gold_answer": "6.2%", "model_answer": "Answer: 6.2%\n\nWorkings (all $ amounts in millions; figures taken from the filing's Consolidated Statements of Income and Consolidated Statements of Cash Flows):\n\nFY2018\n- Operating income (P&L): 20,437\n- Depreciation & amortization (cash flow statement): 10,529\n- Unadjusted EBITDA = 20,437 + 10,529 = 30,966\n- Net sales (P&L): 495,761\n- EBITDA margin = 30,966 / 495,761 = 6.25%\n\nFY2019\n- Operating income (P&L): 21,957\n- Depreciation & amortization (cash flow statement): 10,678\n- Unadjusted EBITDA = 21,957 + 10,678 = 32,635\n- Net sales (P&L): 510,329\n- EBITDA margin = 32,635 / 510,329 = 6.40%\n\nFY2020\n- Operating income (P&L): 20,568\n- Depreciation & amortization (cash flow statement): 10,987\n- Unadjusted EBITDA = 20,568 + 10,987 = 31,555\n- Net sales (P&L): 519,926\n- EBITDA margin = 31,555 / 519,926 = 6.07%\n\nThree-year average (FY2018–FY2020) = average of the three yearly margins = (6.25% + 6.40% + 6.07%) / 3 = 6.237% → rounded to one decimal = 6.2%."}
